{
  "result": {
    "soi_title": {
      "value": "Portfolio of Investments",
      "citations": [
        {
          "type": "Text",
          "bbox": {
            "left": 0.02320261562571806,
            "top": 0.2013888888888889,
            "width": 0.17663397820167293,
            "height": 0.009469696969696961,
            "page": 1,
            "original_page": 1
          },
          "content": "Portfolio of Investments",
          "image_url": null,
          "chart_data": null,
          "confidence": "high",
          "granular_confidence": {
            "extract_confidence": 1.0,
            "parse_confidence": 0.8929622590541839
          },
          "extra": null
        }
      ]
    },
    "as_of_date": {
      "value": "April 30, 2004",
      "citations": [
        {
          "type": "Text",
          "bbox": {
            "left": 0.2071895474701925,
            "top": 0.2013888888888889,
            "width": 0.10294117647058823,
            "height": 0.009469696969696961,
            "page": 1,
            "original_page": 1
          },
          "content": "April 30, 2004",
          "image_url": null,
          "chart_data": null,
          "confidence": "high",
          "granular_confidence": {
            "extract_confidence": 1.0,
            "parse_confidence": 0.8929622590541839
          },
          "extra": null
        }
      ]
    },
    "reporting_basis": {
      "value": "unaudited",
      "citations": [
        {
          "type": "Text",
          "bbox": {
            "left": 0.3173202564513761,
            "top": 0.2013888888888889,
            "width": 0.08088237787383834,
            "height": 0.009469696969696961,
            "page": 1,
            "original_page": 1
          },
          "content": "(unaudited)",
          "image_url": null,
          "chart_data": null,
          "confidence": "low",
          "granular_confidence": {
            "extract_confidence": 0.835,
            "parse_confidence": 0.8929622590541839
          },
          "extra": null
        }
      ]
    },
    "soi_rows": [
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Advertising",
            "citations": []
          }
        ],
        "investment": {
          "value": "Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.31313130259513855,
                "width": 0.4158497005701065,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "$ 1,000,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.31313130259513855,
                "width": 0.08006536029279232,
                "height": 0.007575780153274536,
                "page": 1,
                "original_page": null
              },
              "content": "$ 1,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "$ 1,078,125",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.758169949054718,
                "top": 0.3137626349925995,
                "width": 0.06535947322845459,
                "height": 0.006313115358352661,
                "page": 1,
                "original_page": null
              },
              "content": "1,078,125",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "2.875%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3243463933467865,
                "top": 0.31313130259513855,
                "width": 0.04411765933036804,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "2.875%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2010",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3758170008659363,
                "top": 0.31313130259513855,
                "width": 0.028594762086868286,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "2010",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "currency_raw": {
          "value": "$",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.31313130259513855,
                "width": 0.006535949185490608,
                "height": 0.007575780153274536,
                "page": 1,
                "original_page": null
              },
              "content": "$",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Aerospace and Defense",
            "citations": []
          }
        ],
        "investment": {
          "value": "The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3) (exch. for General Dynamics Corp. common stock)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.3497474789619446,
                "width": 0.5049019604921341,
                "height": 0.020833343267440796,
                "page": 1,
                "original_page": null
              },
              "content": "The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3) (exch. for General Dynamics Corp. common stock) (1)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,500,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04575163498520851,
                "top": 0.35037878155708313,
                "width": 0.0645424835383892,
                "height": 0.006944447755813599,
                "page": 1,
                "original_page": null
              },
              "content": "1,500,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,438,740",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7589869499206543,
                "top": 0.36300504207611084,
                "width": 0.06535947322845459,
                "height": 0.006313145160675049,
                "page": 1,
                "original_page": null
              },
              "content": "1,438,740",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "1%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3839869201183319,
                "top": 0.36300504207611084,
                "width": 0.04330065846443176,
                "height": 0.007575780153274536,
                "page": 1,
                "original_page": null
              },
              "content": "common",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2009",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3839869201183319,
                "top": 0.36300504207611084,
                "width": 0.04330065846443176,
                "height": 0.007575780153274536,
                "page": 1,
                "original_page": null
              },
              "content": "common",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(1)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.48856207728385925,
                  "top": 0.36300504207611084,
                  "width": 0.017156869173049927,
                  "height": 0.007575780153274536,
                  "page": 1,
                  "original_page": null
                },
                "content": "(1)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null,
                "parentBlock": {
                  "type": "Table",
                  "bbox": {
                    "left": 0.02696078431372549,
                    "top": 0.22537878787878787,
                    "width": 0.809640522875817,
                    "height": 0.7209595959595959,
                    "page": 1,
                    "original_page": null
                  },
                  "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                  "image_url": null,
                  "chart_data": null,
                  "confidence": "low",
                  "granular_confidence": {
                    "extract_confidence": null,
                    "parse_confidence": 0.786067078744664
                  },
                  "extra": null
                }
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Automotive",
            "citations": []
          }
        ],
        "investment": {
          "value": "American Axle & Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3) (Acquired 02/06/04 - 02/12/04; Cost $1,044,500)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13235294818878174,
                "top": 0.3983585834503174,
                "width": 0.5334967374801636,
                "height": 0.020833343267440796,
                "page": 1,
                "original_page": null
              },
              "content": "(Baa3) American Axle & Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,000,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04575163498520851,
                "top": 0.39898988604545593,
                "width": 0.0645424835383892,
                "height": 0.007575780153274536,
                "page": 1,
                "original_page": null
              },
              "content": "1,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,010,625",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7589869499206543,
                "top": 0.41161617636680603,
                "width": 0.06372547149658203,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "1,010,625",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "2%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.46405228972435,
                "top": 0.39898988604545593,
                "width": 0.014705866575241089,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "2%",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2024",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3611111044883728,
                "top": 0.41161617636680603,
                "width": 0.029411762952804565,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "Cost",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "cost_raw": {
          "value": "$1,044,500",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3986928164958954,
                "top": 0.41161617636680603,
                "width": 0.07761436700820923,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "$1,044,500)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(1)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.48856207728385925,
                  "top": 0.41161617636680603,
                  "width": 0.017156869173049927,
                  "height": 0.0075757503509521484,
                  "page": 1,
                  "original_page": null
                },
                "content": "(1)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null,
                "parentBlock": {
                  "type": "Table",
                  "bbox": {
                    "left": 0.02696078431372549,
                    "top": 0.22537878787878787,
                    "width": 0.809640522875817,
                    "height": 0.7209595959595959,
                    "page": 1,
                    "original_page": null
                  },
                  "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                  "image_url": null,
                  "chart_data": null,
                  "confidence": "low",
                  "granular_confidence": {
                    "extract_confidence": null,
                    "parse_confidence": 0.786067078744664
                  },
                  "extra": null
                }
              }
            ]
          },
          {
            "value": "(2)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.5179738402366638,
                  "top": 0.41161617636680603,
                  "width": 0.017973899841308594,
                  "height": 0.0075757503509521484,
                  "page": 1,
                  "original_page": null
                },
                "content": "(2)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null,
                "parentBlock": {
                  "type": "Table",
                  "bbox": {
                    "left": 0.02696078431372549,
                    "top": 0.22537878787878787,
                    "width": 0.809640522875817,
                    "height": 0.7209595959595959,
                    "page": 1,
                    "original_page": null
                  },
                  "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                  "image_url": null,
                  "chart_data": null,
                  "confidence": "low",
                  "granular_confidence": {
                    "extract_confidence": null,
                    "parse_confidence": 0.786067078744664
                  },
                  "extra": null
                }
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Automotive",
            "citations": []
          }
        ],
        "investment": {
          "value": "Lear Corp. 0% 2022 cv. sr. notes (Bal)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.42424243688583374,
                "width": 0.27614380419254303,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "Lear Corp. 0% 2022 cv. sr. notes (Bal)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "3,500,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04575163498520851,
                "top": 0.42424243688583374,
                "width": 0.0645424835383892,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "3,500,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,826,563",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7589869499206543,
                "top": 0.4236111044883728,
                "width": 0.06454247236251831,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "1,826,563",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "0%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.21486927568912506,
                "top": 0.42424243688583374,
                "width": 0.013888895511627197,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "0%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2022",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2361111044883728,
                "top": 0.42424243688583374,
                "width": 0.028594791889190674,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "2022",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7573529481887817,
                "top": 0.4488636255264282,
                "width": 0.06617647409439087,
                "height": 0.006313145160675049,
                "page": 1,
                "original_page": null
              },
              "content": "2,837,188",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Automotive",
            "citations": []
          }
        ],
        "label": {
          "value": "",
          "citations": [
            {
              "type": "Table",
              "bbox": {
                "left": 0.02696078431372549,
                "top": 0.22537878787878787,
                "width": 0.809640522875817,
                "height": 0.7209595959595959,
                "page": 1,
                "original_page": 7
              },
              "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "fair_value_raw": {
          "value": "2,837,188",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7573529481887817,
                "top": 0.4488636255264282,
                "width": 0.06617647409439087,
                "height": 0.006313145160675049,
                "page": 1,
                "original_page": null
              },
              "content": "2,837,188",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Banking/Savings and Loan",
            "citations": []
          }
        ],
        "investment": {
          "value": "The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1) (exch. for Fifth Third Bancorp common stock)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.48547980189323425,
                "width": 0.4828431159257889,
                "height": 0.01957067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1) (exch. for Fifth Third Bancorp common stock) (1)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "2,078,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04411764815449715,
                "top": 0.48547980189323425,
                "width": 0.06617647036910057,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "2,078,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "2,059,714",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7573529481887817,
                "top": 0.4968434274196625,
                "width": 0.06535947322845459,
                "height": 0.008207052946090698,
                "page": 1,
                "original_page": null
              },
              "content": "2,059,714",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "0.25%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3758170008659363,
                "top": 0.48547980189323425,
                "width": 0.035947710275650024,
                "height": 0.008207052946090698,
                "page": 1,
                "original_page": null
              },
              "content": "0.25%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2010",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.4199346405228758,
                "top": 0.4678030303030303,
                "width": 0.027777777777777776,
                "height": 0.008207070707070708,
                "page": 1,
                "original_page": 1
              },
              "content": "2010",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(1)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.45669934153556824,
                  "top": 0.48547980189323425,
                  "width": 0.04493466019630432,
                  "height": 0.008207052946090698,
                  "page": 1,
                  "original_page": null
                },
                "content": "medium",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null,
                "parentBlock": {
                  "type": "Table",
                  "bbox": {
                    "left": 0.02696078431372549,
                    "top": 0.22537878787878787,
                    "width": 0.809640522875817,
                    "height": 0.7209595959595959,
                    "page": 1,
                    "original_page": null
                  },
                  "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                  "image_url": null,
                  "chart_data": null,
                  "confidence": "low",
                  "granular_confidence": {
                    "extract_confidence": null,
                    "parse_confidence": 0.786067078744664
                  },
                  "extra": null
                }
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Consumer Goods",
            "citations": []
          }
        ],
        "investment": {
          "value": "Church & Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.5347222089767456,
                "width": 0.39460785686969757,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "Church & Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "2,000,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04411764815449715,
                "top": 0.5353535413742065,
                "width": 0.06617647036910057,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "2,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "2,484,280",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7573529481887817,
                "top": 0.5347222089767456,
                "width": 0.06699347496032715,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "2,484,280",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "5.25%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3243463933467865,
                "top": 0.5347222089767456,
                "width": 0.036764711141586304,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "5.25%",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2033",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.36846405267715454,
                "top": 0.5347222089767456,
                "width": 0.028594762086868286,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "2033",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Data Processing Services",
            "citations": []
          }
        ],
        "investment": {
          "value": "Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.5713383555412292,
                "width": 0.39460785686969757,
                "height": 0.007575809955596924,
                "page": 1,
                "original_page": null
              },
              "content": "Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,500,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04493464156985283,
                "top": 0.5713383555412292,
                "width": 0.06617647036910057,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "1,500,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,387,500",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.758169949054718,
                "top": 0.5719696879386902,
                "width": 0.06617647409439087,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "1,387,500",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "3.875%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3104575276374817,
                "top": 0.5713383555412292,
                "width": 0.043300628662109375,
                "height": 0.007575809955596924,
                "page": 1,
                "original_page": null
              },
              "content": "3.875%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2023",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3611111044883728,
                "top": 0.5713383555412292,
                "width": 0.028594791889190674,
                "height": 0.007575809955596924,
                "page": 1,
                "original_page": null
              },
              "content": "2023",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Electrical Supplies",
            "citations": []
          }
        ],
        "investment": {
          "value": "Graftech International LTD 1.625% 2024 cv. sr. deb. (B2) (Acquired 04/22/04; Cost $999,375)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.6079545617103577,
                "width": 0.40849675238132477,
                "height": 0.02020198106765747,
                "page": 1,
                "original_page": null
              },
              "content": "deb. Graftech International LTD 1.625% 2024 cv. sr. (B2) (Acquired 04/22/04; Cost $999,375) (2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,000,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04493464156985283,
                "top": 0.6092171669006348,
                "width": 0.0645424835383892,
                "height": 0.006313145160675049,
                "page": 1,
                "original_page": null
              },
              "content": "1,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "883,750",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7728758454322815,
                "top": 0.620580792427063,
                "width": 0.049836575984954834,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "883,750",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "1.625%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.33169934153556824,
                "top": 0.6085858345031738,
                "width": 0.04330065846443176,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "1.625%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2024",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.33169934153556824,
                "top": 0.6085858345031738,
                "width": 0.08088237047195435,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "1.625% 2024",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "cost_raw": {
          "value": "$999,375",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.31699347496032715,
                "top": 0.620580792427063,
                "width": 0.06372547149658203,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "$999,375)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(2)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.3937908411026001,
                  "top": 0.620580792427063,
                  "width": 0.015522897243499756,
                  "height": 0.0075757503509521484,
                  "page": 1,
                  "original_page": null
                },
                "content": "(2)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null,
                "parentBlock": {
                  "type": "Table",
                  "bbox": {
                    "left": 0.02696078431372549,
                    "top": 0.22537878787878787,
                    "width": 0.809640522875817,
                    "height": 0.7209595959595959,
                    "page": 1,
                    "original_page": null
                  },
                  "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                  "image_url": null,
                  "chart_data": null,
                  "confidence": "low",
                  "granular_confidence": {
                    "extract_confidence": null,
                    "parse_confidence": 0.786067078744664
                  },
                  "extra": null
                }
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Energy",
            "citations": []
          }
        ],
        "investment": {
          "value": "Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.6578282713890076,
                "width": 0.3513071984052658,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,900,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04493464156985283,
                "top": 0.6584596037864685,
                "width": 0.06535947695374489,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "1,900,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "2,006,457",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7573529481887817,
                "top": 0.6578282713890076,
                "width": 0.06617647409439087,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "2,006,457",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "5.25%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.258169949054718,
                "top": 0.6578282713890076,
                "width": 0.036764681339263916,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "5.25%",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2010",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.30228757858276367,
                "top": 0.6578282713890076,
                "width": 0.029411762952804565,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "2010",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Entertainment",
            "citations": []
          }
        ],
        "investment": {
          "value": "Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR) (Acquired 02/11/04 - 02/25/04; Cost $1,246,250)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13235294818878174,
                "top": 0.6944444179534912,
                "width": 0.42401957511901855,
                "height": 0.020202040672302246,
                "page": 1,
                "original_page": null
              },
              "content": "Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR) (Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,250,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04493464156985283,
                "top": 0.6950757503509521,
                "width": 0.06535947695374489,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "1,250,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,201,563",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.758169949054718,
                "top": 0.7064393758773804,
                "width": 0.06535947322845459,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "1,201,563",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "1.875%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3325163424015045,
                "top": 0.6944444179534912,
                "width": 0.04330065846443176,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "1.875%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2011",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.383169949054718,
                "top": 0.6944444179534912,
                "width": 0.029411762952804565,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "2011",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "cost_raw": {
          "value": "$1,246,250",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3986928164958954,
                "top": 0.7070707082748413,
                "width": 0.07761436700820923,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "$1,246,250)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(2)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.48856207728385925,
                  "top": 0.7070707082748413,
                  "width": 0.016339868307113647,
                  "height": 0.0075757503509521484,
                  "page": 1,
                  "original_page": null
                },
                "content": "(2)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null,
                "parentBlock": {
                  "type": "Table",
                  "bbox": {
                    "left": 0.02696078431372549,
                    "top": 0.22537878787878787,
                    "width": 0.809640522875817,
                    "height": 0.7209595959595959,
                    "page": 1,
                    "original_page": null
                  },
                  "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                  "image_url": null,
                  "chart_data": null,
                  "confidence": "low",
                  "granular_confidence": {
                    "extract_confidence": null,
                    "parse_confidence": 0.786067078744664
                  },
                  "extra": null
                }
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Financial and Insurance",
            "citations": []
          }
        ],
        "investment": {
          "value": "Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3) (Acquired 04/22/04; Cost $1,265,000)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.743686854839325,
                "width": 0.4313725382089615,
                "height": 0.020202040672302246,
                "page": 1,
                "original_page": null
              },
              "content": "Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3) (Acquired 04/22/04; Cost $1,265,000) (2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,250,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04493464156985283,
                "top": 0.6950757503509521,
                "width": 0.06535947695374489,
                "height": 0.05618685483932495,
                "page": 1,
                "original_page": null
              },
              "content": "1,250,000 1,250,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,270,313",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7589869499206543,
                "top": 0.7569444179534912,
                "width": 0.06535947322845459,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "1,270,313",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "3.75%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3104575276374817,
                "top": 0.743686854839325,
                "width": 0.035947710275650024,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "3.75%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2014",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.35375815629959106,
                "top": 0.743686854839325,
                "width": 0.029411792755126953,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "2014",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "cost_raw": {
          "value": "$1,265,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.31781044602394104,
                "top": 0.756313145160675,
                "width": 0.0784313976764679,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "$1,265,000)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(2)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.4076797366142273,
                  "top": 0.756313145160675,
                  "width": 0.017156869173049927,
                  "height": 0.0075757503509521484,
                  "page": 1,
                  "original_page": null
                },
                "content": "(2)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null,
                "parentBlock": {
                  "type": "Table",
                  "bbox": {
                    "left": 0.02696078431372549,
                    "top": 0.22537878787878787,
                    "width": 0.809640522875817,
                    "height": 0.7209595959595959,
                    "page": 1,
                    "original_page": null
                  },
                  "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                  "image_url": null,
                  "chart_data": null,
                  "confidence": "low",
                  "granular_confidence": {
                    "extract_confidence": null,
                    "parse_confidence": 0.786067078744664
                  },
                  "extra": null
                }
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Financial and Insurance",
            "citations": []
          }
        ],
        "investment": {
          "value": "Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal) (conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 - 12/05/01; Cost $1,007,750)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.7683081030845642,
                "width": 0.5294117480516434,
                "height": 0.03219693899154663,
                "page": 1,
                "original_page": null
              },
              "content": "Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal) (conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 - 12/05/01; Cost $1,007,750) (2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,000,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04575163498520851,
                "top": 0.7683081030845642,
                "width": 0.06535947695374489,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "1,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "945,625",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7728758454322815,
                "top": 0.7929292917251587,
                "width": 0.049836575984954834,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "945,625",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "3.25%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3619281053543091,
                "top": 0.7683081030845642,
                "width": 0.035947710275650024,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "3.25%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2021",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.40522876381874084,
                "top": 0.7683081030845642,
                "width": 0.028594762086868286,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "2021",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "cost_raw": {
          "value": "$1,007,750",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.24428103864192963,
                "top": 0.7929292917251587,
                "width": 0.07761438190937042,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "$1,007,750)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(2)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.3341503143310547,
                  "top": 0.7929292917251587,
                  "width": 0.017156869173049927,
                  "height": 0.0075757503509521484,
                  "page": 1,
                  "original_page": null
                },
                "content": "(2)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null,
                "parentBlock": {
                  "type": "Table",
                  "bbox": {
                    "left": 0.02696078431372549,
                    "top": 0.22537878787878787,
                    "width": 0.809640522875817,
                    "height": 0.7209595959595959,
                    "page": 1,
                    "original_page": null
                  },
                  "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                  "image_url": null,
                  "chart_data": null,
                  "confidence": "low",
                  "granular_confidence": {
                    "extract_confidence": null,
                    "parse_confidence": 0.786067078744664
                  },
                  "extra": null
                }
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13071895424836602,
                "top": 0.8175505050505051,
                "width": 0.06699346405228758,
                "height": 0.007575757575757576,
                "page": 1,
                "original_page": 1
              },
              "content": "SUBTOTAL",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Financial and Insurance",
            "citations": []
          }
        ],
        "label": {
          "value": "",
          "citations": [
            {
              "type": "Table",
              "bbox": {
                "left": 0.02696078431372549,
                "top": 0.22537878787878787,
                "width": 0.809640522875817,
                "height": 0.7209595959595959,
                "page": 1,
                "original_page": 7
              },
              "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "fair_value_raw": {
          "value": "2,215,938",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.758169949054718,
                "top": 0.8181818127632141,
                "width": 0.06535947322845459,
                "height": 0.006313145160675049,
                "page": 1,
                "original_page": null
              },
              "content": "2,215,938",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Health Care",
            "citations": []
          }
        ],
        "investment": {
          "value": "AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13235294818878174,
                "top": 0.8554292917251587,
                "width": 0.37254899740219116,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,000,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04575163498520851,
                "top": 0.8554292917251587,
                "width": 0.06372549012303352,
                "height": 0.006313145160675049,
                "page": 1,
                "original_page": null
              },
              "content": "1,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,177,950",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7589869499206543,
                "top": 0.8554292917251587,
                "width": 0.06454247236251831,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "1,177,950",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "5%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3096405267715454,
                "top": 0.8554292917251587,
                "width": 0.013888895511627197,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "5%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2007",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.33169934153556824,
                "top": 0.8554292917251587,
                "width": 0.028594762086868286,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "2007",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Health Care",
            "citations": []
          }
        ],
        "investment": {
          "value": "Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.8667929172515869,
                "width": 0.44689543545246124,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,000,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04575163498520851,
                "top": 0.8667929172515869,
                "width": 0.06372549012303352,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "1,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,064,100",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7589869499206543,
                "top": 0.8674242496490479,
                "width": 0.06454247236251831,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "1,064,100",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "4.25%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3611111044883728,
                "top": 0.8667929172515869,
                "width": 0.036764711141586304,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "4.25%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2008",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.40522876381874084,
                "top": 0.8667929172515869,
                "width": 0.028594762086868286,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "2008",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Health Care",
            "citations": []
          }
        ],
        "investment": {
          "value": "LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.879419207572937,
                "width": 0.40931375324726105,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "500,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.05964052304625511,
                "top": 0.879419207572937,
                "width": 0.050653595477342606,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "500,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "525,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7728758454322815,
                "top": 0.8787878751754761,
                "width": 0.05065357685089111,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "525,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "4.50%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3235294222831726,
                "top": 0.879419207572937,
                "width": 0.036764681339263916,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "4.50%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2009",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.4060457646846771,
                "top": 0.879419207572937,
                "width": 0.019607841968536377,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "cv.",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Health Care",
            "citations": []
          }
        ],
        "investment": {
          "value": "Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR) (Acquired 04/30/04; Cost $125,000)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13235294818878174,
                "top": 0.8914141654968262,
                "width": 0.4313725233078003,
                "height": 0.020833313465118408,
                "page": 1,
                "original_page": null
              },
              "content": "Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR) $125,000) (2) (Acquired 04/30/04; Cost",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "125,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.059640522875817,
                "top": 0.9040404040404041,
                "width": 0.049836601307189546,
                "height": 0.008838383838383838,
                "page": 1,
                "original_page": 1
              },
              "content": "125,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "126,094",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7728758454322815,
                "top": 0.9027777910232544,
                "width": 0.049836575984954834,
                "height": 0.008838355541229248,
                "page": 1,
                "original_page": null
              },
              "content": "126,094",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "4.875%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3096405267715454,
                "top": 0.8914141654968262,
                "width": 0.04330065846443176,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "4.875%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2024",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.31699347496032715,
                "top": 0.9027777910232544,
                "width": 0.06290850043296814,
                "height": 0.008838355541229248,
                "page": 1,
                "original_page": null
              },
              "content": "$125,000)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "cost_raw": {
          "value": "$125,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.27941176295280457,
                "top": 0.9027777910232544,
                "width": 0.10049021244049072,
                "height": 0.008838355541229248,
                "page": 1,
                "original_page": null
              },
              "content": "$125,000) Cost",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(2)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.4730392156862745,
                  "top": 0.9040404040404041,
                  "width": 0.016339869281045753,
                  "height": 0.008838383838383838,
                  "page": 1,
                  "original_page": 1
                },
                "content": "(2)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Health Care",
            "citations": []
          }
        ],
        "investment": {
          "value": "Mentor Corp. 2.75% 2024 cv. sub. notes (NR). (Acquired 12/17/03 - 01/30/04; Cost $941,250)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13235294818878174,
                "top": 0.9160353541374207,
                "width": 0.3292483687400818,
                "height": 0.020202040672302246,
                "page": 1,
                "original_page": null
              },
              "content": "Mentor Corp. 2.75% 2024 cv. sub. notes (NR). (Acquired 12/17/03 - 01/30/04; Cost $941,250)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "875,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.05964052304625511,
                "top": 0.9160353541374207,
                "width": 0.04983660206198692,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "875,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,095,938",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.758169949054718,
                "top": 0.9292929172515869,
                "width": 0.06617647409439087,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "1,095,938",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "2.75%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.22875817120075226,
                "top": 0.9160353541374207,
                "width": 0.03676469624042511,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "2.75%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2024",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2883986830711365,
                "top": 0.9286616444587708,
                "width": 0.1021241843700409,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "01/30/04; Cost",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "cost_raw": {
          "value": "$941,250",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3986928164958954,
                "top": 0.9286616444587708,
                "width": 0.06290850043296814,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "$941,250)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(2)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.47385621070861816,
                  "top": 0.9286616444587708,
                  "width": 0.017156869173049927,
                  "height": 0.0075757503509521484,
                  "page": 1,
                  "original_page": null
                },
                "content": "(2)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null,
                "parentBlock": {
                  "type": "Table",
                  "bbox": {
                    "left": 0.02696078431372549,
                    "top": 0.22537878787878787,
                    "width": 0.809640522875817,
                    "height": 0.7209595959595959,
                    "page": 1,
                    "original_page": null
                  },
                  "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                  "image_url": null,
                  "chart_data": null,
                  "confidence": "low",
                  "granular_confidence": {
                    "extract_confidence": null,
                    "parse_confidence": 0.786067078744664
                  },
                  "extra": null
                }
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7581699346405228,
                "top": 0.03598484848484849,
                "width": 0.004901960784313725,
                "height": 0.0006313131313131314,
                "page": 2,
                "original_page": 2
              },
              "content": "SUBTOTAL",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7503263920545578
              },
              "extra": null
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Health Care",
            "citations": []
          }
        ],
        "fair_value_raw": {
          "value": "3,989,082",
          "citations": [
            {
              "type": "Header",
              "bbox": {
                "left": 0.7581699346405228,
                "top": 0.029671717171717172,
                "width": 0.06454248366013071,
                "height": 0.0075757575757575794,
                "page": 2,
                "original_page": 2
              },
              "content": "3,989,082",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7503263920545578
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Office Equipment",
            "citations": []
          }
        ],
        "investment": {
          "value": "IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions, Inc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13562092185020447,
                "top": 0.7070707082748413,
                "width": 0.36928102374076843,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.13562091503267973,
                "top": 0.7178030303030303,
                "width": 0.3423202614379085,
                "height": 0.00946969696969697,
                "page": 1,
                "original_page": 1
              },
              "content": "IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions, Inc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.7323232293128967,
                "width": 0.22875817120075226,
                "height": 0.006313145160675049,
                "page": 1,
                "original_page": null
              },
              "content": "Financial and Insurance - 1.98",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.743686854839325,
                "width": 0.4313725382089615,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.13643790781497955,
                "top": 0.756313145160675,
                "width": 0.28839869797229767,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "(Acquired 04/22/04; Cost $1,265,000) (2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "$ 1,750,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.028594771241830064,
                "top": 0.7058080808080808,
                "width": 0.08251633986928104,
                "height": 0.008838383838383838,
                "page": 1,
                "original_page": 1
              },
              "content": "$ 1,750,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "$ 1,828,750",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.758169949054718,
                "top": 0.7064393758773804,
                "width": 0.06535947322845459,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "1,201,563",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "5%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3096405267715454,
                "top": 0.8554292917251587,
                "width": 0.013888895511627197,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "5%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2007",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.33169934153556824,
                "top": 0.8554292917251587,
                "width": 0.028594762086868286,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "2007",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "cost_raw": {
          "value": "$1,746,250",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3611111044883728,
                "top": 0.7070707082748413,
                "width": 0.11519607901573181,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "Cost $1,246,250)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(2)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.48856207728385925,
                  "top": 0.7070707082748413,
                  "width": 0.016339868307113647,
                  "height": 0.0075757503509521484,
                  "page": 1,
                  "original_page": null
                },
                "content": "(2)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null,
                "parentBlock": {
                  "type": "Table",
                  "bbox": {
                    "left": 0.02696078431372549,
                    "top": 0.22537878787878787,
                    "width": 0.809640522875817,
                    "height": 0.7209595959595959,
                    "page": 1,
                    "original_page": null
                  },
                  "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                  "image_url": null,
                  "chart_data": null,
                  "confidence": "low",
                  "granular_confidence": {
                    "extract_confidence": null,
                    "parse_confidence": 0.786067078744664
                  },
                  "extra": null
                }
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Pharmaceuticals",
            "citations": []
          }
        ],
        "investment": {
          "value": "Alza Corp. 0% 2020 cv. sub. deb. (Aal) (exch. for Johnson & Johnson common stock)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.31313130259513855,
                "width": 0.4158497005701065,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.1315359477124183,
                "top": 0.3207070707070707,
                "width": 0.3464052287581699,
                "height": 0.008838383838383838,
                "page": 1,
                "original_page": 1
              },
              "content": "Alza Corp. 0% 2020 cv. sub. deb. (Aal) (exch. for Johnson & Johnson common stock)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "quantity_raw": {
          "value": "2,000,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04411764815449715,
                "top": 0.5353535413742065,
                "width": 0.06617647036910057,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "2,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,507,500",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.758169949054718,
                "top": 0.3137626349925995,
                "width": 0.06535947322845459,
                "height": 0.006313115358352661,
                "page": 1,
                "original_page": null
              },
              "content": "1,078,125",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "0%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.21486927568912506,
                "top": 0.42424243688583374,
                "width": 0.013888895511627197,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "0%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2020",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3758170008659363,
                "top": 0.31313130259513855,
                "width": 0.028594762086868286,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "2010",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Pharmaceuticals",
            "citations": []
          }
        ],
        "investment": {
          "value": "Amgen, Inc. 0% 2032 LYONS (A2)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.42424243688583374,
                "width": 0.27614380419254303,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "Lear Corp. 0% 2022 cv. sr. notes (Bal)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "2,000,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04411764815449715,
                "top": 0.5353535413742065,
                "width": 0.06617647036910057,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "2,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,478,973",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.758169949054718,
                "top": 0.3137626349925995,
                "width": 0.06535947322845459,
                "height": 0.006313115358352661,
                "page": 1,
                "original_page": null
              },
              "content": "1,078,125",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "0%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.21486927568912506,
                "top": 0.42424243688583374,
                "width": 0.013888895511627197,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "0%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2032",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2728758156299591,
                "top": 0.42424243688583374,
                "width": 0.04901960492134094,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "cv. sr.",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(1)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.4861111111111111,
                  "top": 0.42297979797979796,
                  "width": 0.017973856209150325,
                  "height": 0.008207070707070708,
                  "page": 1,
                  "original_page": 1
                },
                "content": "(1)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Pharmaceuticals",
            "citations": []
          }
        ],
        "investment": {
          "value": "Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.6578282713890076,
                "width": 0.3513071984052658,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,250,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04493464156985283,
                "top": 0.6950757503509521,
                "width": 0.06535947695374489,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "1,250,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,744,531",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7573529481887817,
                "top": 0.6578282713890076,
                "width": 0.06617647409439087,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "2,006,457",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "2%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.30228757858276367,
                "top": 0.6578282713890076,
                "width": 0.05718955397605896,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "2010 cv.",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2007",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.33169934153556824,
                "top": 0.8554292917251587,
                "width": 0.028594762086868286,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "2007",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Pharmaceuticals",
            "citations": []
          }
        ],
        "investment": {
          "value": "Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR) (Acquired 03/31/04 - 04/23/04; Cost $1,208,750)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.1315359477124183,
                "top": 0.5422979797979798,
                "width": 0.3954248366013072,
                "height": 0.00946969696969697,
                "page": 1,
                "original_page": 1
              },
              "content": "Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR) (Acquired 03/31/04 - 04/23/04; Cost $1,208,750)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.5593434572219849,
                "width": 0.23529411852359772,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "Data Processing Services -- 1.2%",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,125,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.06535947712418301,
                "top": 0.5422979797979798,
                "width": 0.0457516339869281,
                "height": 0.007575757575757576,
                "page": 1,
                "original_page": 1
              },
              "content": "1,125,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,157,614",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7573529411764706,
                "top": 0.37563131313131315,
                "width": 0.06699346405228758,
                "height": 0.00946969696969697,
                "page": 1,
                "original_page": 1
              },
              "content": "1,157,614",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "interest_rate_raw": {
          "value": "1.25%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.33986928104575165,
                "top": 0.5422979797979798,
                "width": 0.028594771241830064,
                "height": 0.007575757575757576,
                "page": 1,
                "original_page": 1
              },
              "content": "1.25%",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "maturity_date": {
          "value": "2024",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.36437908496732024,
                "top": 0.5422979797979798,
                "width": 0.025326797385620915,
                "height": 0.007575757575757576,
                "page": 1,
                "original_page": 1
              },
              "content": "2024",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "cost_raw": {
          "value": "$1,208,750",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3570261437908497,
                "top": 0.37563131313131315,
                "width": -0.03758169934640523,
                "height": 0.00946969696969697,
                "page": 1,
                "original_page": 1
              },
              "content": "$1,208,750",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(2)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.3333333333333333,
                  "top": 0.37563131313131315,
                  "width": 0.021241830065359478,
                  "height": 0.00946969696969697,
                  "page": 1,
                  "original_page": 1
                },
                "content": "(2)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Pharmaceuticals",
            "citations": []
          }
        ],
        "investment": {
          "value": "Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13235294818878174,
                "top": 0.8914141654968262,
                "width": 0.4313725233078003,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "500,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.05964052304625511,
                "top": 0.879419207572937,
                "width": 0.050653595477342606,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "500,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "506,250",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3096405267715454,
                "top": 0.8914141654968262,
                "width": 0.08088234066963196,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "4.875% 2024",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "4.50%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3235294222831726,
                "top": 0.879419207572937,
                "width": 0.036764681339263916,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "4.50%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2008",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.40522876381874084,
                "top": 0.8667929172515869,
                "width": 0.028594762086868286,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "2008",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Pharmaceuticals",
            "citations": []
          }
        ],
        "investment": {
          "value": "Ivax Corp. 1.50% 2024 cv. sr. notes (NR) (Acquired 02/27/04; Cost $1,262,103)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13643790781497955,
                "top": 0.41161617636680603,
                "width": 0.39950983226299286,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,250,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04493464156985283,
                "top": 0.6950757503509521,
                "width": 0.06535947695374489,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "1,250,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,233,088",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7589869499206543,
                "top": 0.41161617636680603,
                "width": 0.06372547149658203,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "1,010,625",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "1.50%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2883986830711365,
                "top": 0.41161617636680603,
                "width": 0.06372550129890442,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "02/12/04;",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2024",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3611111044883728,
                "top": 0.41161617636680603,
                "width": 0.029411762952804565,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "Cost",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "cost_raw": {
          "value": "$1,262,103",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3986928164958954,
                "top": 0.41161617636680603,
                "width": 0.07761436700820923,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "$1,044,500)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(1)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.48856207728385925,
                  "top": 0.41161617636680603,
                  "width": 0.017156869173049927,
                  "height": 0.0075757503509521484,
                  "page": 1,
                  "original_page": null
                },
                "content": "(1)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null,
                "parentBlock": {
                  "type": "Table",
                  "bbox": {
                    "left": 0.02696078431372549,
                    "top": 0.22537878787878787,
                    "width": 0.809640522875817,
                    "height": 0.7209595959595959,
                    "page": 1,
                    "original_page": null
                  },
                  "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                  "image_url": null,
                  "chart_data": null,
                  "confidence": "low",
                  "granular_confidence": {
                    "extract_confidence": null,
                    "parse_confidence": 0.786067078744664
                  },
                  "extra": null
                }
              }
            ]
          },
          {
            "value": "(2)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.5179738402366638,
                  "top": 0.41161617636680603,
                  "width": 0.017973899841308594,
                  "height": 0.0075757503509521484,
                  "page": 1,
                  "original_page": null
                },
                "content": "(2)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null,
                "parentBlock": {
                  "type": "Table",
                  "bbox": {
                    "left": 0.02696078431372549,
                    "top": 0.22537878787878787,
                    "width": 0.809640522875817,
                    "height": 0.7209595959595959,
                    "page": 1,
                    "original_page": null
                  },
                  "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                  "image_url": null,
                  "chart_data": null,
                  "confidence": "low",
                  "granular_confidence": {
                    "extract_confidence": null,
                    "parse_confidence": 0.786067078744664
                  },
                  "extra": null
                }
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Pharmaceuticals",
            "citations": []
          }
        ],
        "investment": {
          "value": "Medarex, Inc. 2.25% 2011 cv. sr. notes (NR) (Acquired 04/27/04 - 04/28/04; Cost $1,055,000)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13643790781497955,
                "top": 0.41161617636680603,
                "width": 0.39950983226299286,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.42424243688583374,
                "width": 0.27614380419254303,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "Lear Corp. 0% 2022 cv. sr. notes (Bal)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,050,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7589869499206543,
                "top": 0.41161617636680603,
                "width": 0.06372547149658203,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "1,010,625",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,031,625",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.758169949054718,
                "top": 0.3137626349925995,
                "width": 0.06535947322845459,
                "height": 0.006313115358352661,
                "page": 1,
                "original_page": null
              },
              "content": "1,078,125",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "2.25%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2883986830711365,
                "top": 0.41161617636680603,
                "width": 0.1021241843700409,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "02/12/04; Cost",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2011",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.383169949054718,
                "top": 0.6944444179534912,
                "width": 0.029411762952804565,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "2011",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "cost_raw": {
          "value": "$1,055,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04575163498520851,
                "top": 0.31313130259513855,
                "width": 0.0645424835383892,
                "height": 0.007575780153274536,
                "page": 1,
                "original_page": null
              },
              "content": "1,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(2)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.48856207728385925,
                  "top": 0.41161617636680603,
                  "width": 0.017156869173049927,
                  "height": 0.0075757503509521484,
                  "page": 1,
                  "original_page": null
                },
                "content": "(1)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null,
                "parentBlock": {
                  "type": "Table",
                  "bbox": {
                    "left": 0.02696078431372549,
                    "top": 0.22537878787878787,
                    "width": 0.809640522875817,
                    "height": 0.7209595959595959,
                    "page": 1,
                    "original_page": null
                  },
                  "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                  "image_url": null,
                  "chart_data": null,
                  "confidence": "low",
                  "granular_confidence": {
                    "extract_confidence": null,
                    "parse_confidence": 0.786067078744664
                  },
                  "extra": null
                }
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Pharmaceuticals",
            "citations": []
          }
        ],
        "investment": {
          "value": "Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB) (exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13562092185020447,
                "top": 0.9286616444587708,
                "width": 0.3553921580314636,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.13480392156862744,
                "top": 0.9387626262626263,
                "width": 0.3431372549019608,
                "height": 0.007575757575757576,
                "page": 1,
                "original_page": 1
              },
              "content": "Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB) (exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "quantity_raw": {
          "value": "750,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.059640522875817,
                "top": 0.9292929292929293,
                "width": 0.051470588235294115,
                "height": 0.007575757575757576,
                "page": 1,
                "original_page": 1
              },
              "content": "750,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,085,250",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3986928164958954,
                "top": 0.9286616444587708,
                "width": 0.06290850043296814,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "$941,250)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "0.75%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.20751634240150452,
                "top": 0.9286616444587708,
                "width": 0.07189542055130005,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "12/17/03 -",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2021",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.40522876381874084,
                "top": 0.7683081030845642,
                "width": 0.028594762086868286,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "2021",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Pharmaceuticals",
            "citations": []
          }
        ],
        "investment": {
          "value": "Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB) (exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13235294818878174,
                "top": 0.39898988604545593,
                "width": 0.4395424723625183,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "American Axle & Manufacturing Holdings, Inc. 2% 2024 cv. sr.",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.13643790781497955,
                "top": 0.41161617636680603,
                "width": 0.33986927568912506,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "(Acquired 02/06/04 - 02/12/04; Cost $1,044,500)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,000,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04575163498520851,
                "top": 0.39898988604545593,
                "width": 0.0645424835383892,
                "height": 0.007575780153274536,
                "page": 1,
                "original_page": null
              },
              "content": "1,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,010,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04575163498520851,
                "top": 0.39898988604545593,
                "width": 0.0645424835383892,
                "height": 0.007575780153274536,
                "page": 1,
                "original_page": null
              },
              "content": "1,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "0.50%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.23692810535430908,
                "top": 0.39898988604545593,
                "width": 0.10866013169288635,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "& Manufacturing",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2024",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.35457515716552734,
                "top": 0.39898988604545593,
                "width": 0.06372550129890442,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "Holdings,",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Pharmaceuticals",
            "citations": []
          }
        ],
        "investment": {
          "value": "Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB) (exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.879419207572937,
                "width": 0.40931375324726105,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.13235294818878174,
                "top": 0.8914141654968262,
                "width": 0.3145424723625183,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "Matria Healthcare, Inc. 4.875% 2024 cv. sr.",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,000,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.05964052304625511,
                "top": 0.879419207572937,
                "width": 0.050653595477342606,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "500,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,018,750",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7728758454322815,
                "top": 0.7929292917251587,
                "width": 0.049836575984954834,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "945,625",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "0.25%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3758170008659363,
                "top": 0.48547980189323425,
                "width": 0.035947710275650024,
                "height": 0.008207052946090698,
                "page": 1,
                "original_page": null
              },
              "content": "0.25%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2024",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.36846405267715454,
                "top": 0.879419207572937,
                "width": 0.028594762086868286,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "2009",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.8421717286109924,
                "width": 0.138888880610466,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "Health Care -- 3.4%",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Pharmaceuticals",
            "citations": []
          }
        ],
        "label": {
          "value": "",
          "citations": [
            {
              "type": "Table",
              "bbox": {
                "left": 0.02696078431372549,
                "top": 0.22537878787878787,
                "width": 0.809640522875817,
                "height": 0.7209595959595959,
                "page": 1,
                "original_page": 7
              },
              "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "fair_value_raw": {
          "value": "11,773,581",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7589869499206543,
                "top": 0.8554292917251587,
                "width": 0.06454247236251831,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "1,177,950",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Retail",
            "citations": []
          }
        ],
        "investment": {
          "value": "Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR) (Acquired 02/11/04 - 03/15/04; Cost $917,772)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.4722222089767456,
                "width": 0.4828431159257889,
                "height": 0.021464645862579346,
                "page": 1,
                "original_page": null
              },
              "content": "and Banking/Savings The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,300,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.47285354137420654,
                "width": 0.10947711765766144,
                "height": 0.020833313465118408,
                "page": 1,
                "original_page": null
              },
              "content": "Banking/Savings The",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "882,375",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7728758454322815,
                "top": 0.620580792427063,
                "width": 0.049836575984954834,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "883,750",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "1.6061%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.33986929059028625,
                "top": 0.48547980189323425,
                "width": 0.026960760354995728,
                "height": 0.008207052946090698,
                "page": 1,
                "original_page": null
              },
              "content": "Inc.",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2024",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3758170008659363,
                "top": 0.48547980189323425,
                "width": 0.035947710275650024,
                "height": 0.008207052946090698,
                "page": 1,
                "original_page": null
              },
              "content": "0.25%",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "cost_raw": {
          "value": "$917,772",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7573529411764706,
                "top": 0.4791666666666667,
                "width": 0.0661764705882353,
                "height": 0.007575757575757576,
                "page": 1,
                "original_page": 1
              },
              "content": "$917,772",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(2)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.45669934153556824,
                  "top": 0.48547980189323425,
                  "width": 0.04493466019630432,
                  "height": 0.008207052946090698,
                  "page": 1,
                  "original_page": null
                },
                "content": "medium",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null,
                "parentBlock": {
                  "type": "Table",
                  "bbox": {
                    "left": 0.02696078431372549,
                    "top": 0.22537878787878787,
                    "width": 0.809640522875817,
                    "height": 0.7209595959595959,
                    "page": 1,
                    "original_page": null
                  },
                  "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                  "image_url": null,
                  "chart_data": null,
                  "confidence": "low",
                  "granular_confidence": {
                    "extract_confidence": null,
                    "parse_confidence": 0.786067078744664
                  },
                  "extra": null
                }
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Retail",
            "citations": []
          }
        ],
        "investment": {
          "value": "Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR) (Acquired 11/13/03 - 12/19/03; Cost $1,015,985)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13235294818878174,
                "top": 0.2998737394809723,
                "width": 0.1388888955116272,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "0.9% Advertising --",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,000,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.0457516339869281,
                "top": 0.2948232323232323,
                "width": 0.06535947712418301,
                "height": 0.008838383838383838,
                "page": 1,
                "original_page": 1
              },
              "content": "1,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,165,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7573529411764706,
                "top": 0.2948232323232323,
                "width": 0.06699346405228758,
                "height": 0.008838383838383838,
                "page": 1,
                "original_page": 1
              },
              "content": "1,165,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "interest_rate_raw": {
          "value": "5%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3096405267715454,
                "top": 0.8554292917251587,
                "width": 0.013888895511627197,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "5%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2024",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3619281045751634,
                "top": 0.2948232323232323,
                "width": 0.029411764705882353,
                "height": 0.008838383838383838,
                "page": 1,
                "original_page": 1
              },
              "content": "2024",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "cost_raw": {
          "value": "$1,015,985",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.375,
                "top": 0.2948232323232323,
                "width": 0.056372549019607844,
                "height": 0.008838383838383838,
                "page": 1,
                "original_page": 1
              },
              "content": "$1,015,985",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(2)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.47549019607843135,
                  "top": 0.2948232323232323,
                  "width": 0.02042483660130719,
                  "height": 0.008838383838383838,
                  "page": 1,
                  "original_page": 1
                },
                "content": "(2)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Retail",
            "citations": []
          }
        ],
        "investment": {
          "value": "Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.5593434572219849,
                "width": 0.23529411852359772,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "Data Processing Services -- 1.2%",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,500,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04575163498520851,
                "top": 0.35037878155708313,
                "width": 0.0645424835383892,
                "height": 0.006944447755813599,
                "page": 1,
                "original_page": null
              },
              "content": "1,500,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,629,375",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7728758454322815,
                "top": 0.620580792427063,
                "width": 0.049836575984954834,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "883,750",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "4.75%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.31699347496032715,
                "top": 0.5593434572219849,
                "width": 0.05147057771682739,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "-- 1.2%",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2012",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.31699347496032715,
                "top": 0.5593434572219849,
                "width": 0.05147057771682739,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "-- 1.2%",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Retail",
            "citations": []
          }
        ],
        "investment": {
          "value": "Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.1315359477124183,
                "top": 0.44696969696969696,
                "width": 0.5065359477124183,
                "height": 0.008838383838383838,
                "page": 1,
                "original_page": 1
              },
              "content": "Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "quantity_raw": {
          "value": "1,500,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04575163498520851,
                "top": 0.35037878155708313,
                "width": 0.0645424835383892,
                "height": 0.006944447755813599,
                "page": 1,
                "original_page": null
              },
              "content": "1,500,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,289,063",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7573529481887817,
                "top": 0.4488636255264282,
                "width": 0.06617647409439087,
                "height": 0.006313145160675049,
                "page": 1,
                "original_page": null
              },
              "content": "2,837,188",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "0%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.21486927568912506,
                "top": 0.42424243688583374,
                "width": 0.013888895511627197,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "0%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2017",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2638888888888889,
                "top": 0.44696969696969696,
                "width": 0.02696078431372549,
                "height": 0.008838383838383838,
                "page": 1,
                "original_page": 1
              },
              "content": "2017",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Retail",
            "citations": []
          }
        ],
        "investment": {
          "value": "Reebok International Ltd. 2% 2024 cv. deb. (BBB) (Acquired 04/27/04; Cost $1,004,375)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.6079545617103577,
                "width": 0.40849675238132477,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "deb. Graftech International LTD 1.625% 2024 cv. sr. (B2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.13562092185020447,
                "top": 0.620580792427063,
                "width": 0.2736928164958954,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "(Acquired 04/22/04; Cost $999,375) (2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,000,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04493464156985283,
                "top": 0.6092171669006348,
                "width": 0.0645424835383892,
                "height": 0.006313145160675049,
                "page": 1,
                "original_page": null
              },
              "content": "1,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,003,750",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7728758454322815,
                "top": 0.620580792427063,
                "width": 0.049836575984954834,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "883,750",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "2%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.30310457944869995,
                "top": 0.6085858345031738,
                "width": 0.021241813898086548,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "LTD",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2024",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.383169949054718,
                "top": 0.6085858345031738,
                "width": 0.029411762952804565,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "2024",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "cost_raw": {
          "value": "$1,004,375",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.31699347496032715,
                "top": 0.620580792427063,
                "width": 0.0923202633857727,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "$999,375) (2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(1)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.4861111111111111,
                  "top": 0.6186868686868687,
                  "width": 0.018790849673202614,
                  "height": 0.008838383838383838,
                  "page": 1,
                  "original_page": 1
                },
                "content": "(1)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            ]
          },
          {
            "value": "(2)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.3937908411026001,
                  "top": 0.620580792427063,
                  "width": 0.015522897243499756,
                  "height": 0.0075757503509521484,
                  "page": 1,
                  "original_page": null
                },
                "content": "(2)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null,
                "parentBlock": {
                  "type": "Table",
                  "bbox": {
                    "left": 0.02696078431372549,
                    "top": 0.22537878787878787,
                    "width": 0.809640522875817,
                    "height": 0.7209595959595959,
                    "page": 1,
                    "original_page": null
                  },
                  "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                  "image_url": null,
                  "chart_data": null,
                  "confidence": "low",
                  "granular_confidence": {
                    "extract_confidence": null,
                    "parse_confidence": 0.786067078744664
                  },
                  "extra": null
                }
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Retail",
            "citations": []
          }
        ],
        "investment": {
          "value": "Saks, Inc. 2% 2024 cv. sr. notes (Ba3). (Acquired 03/17/04 - 04/23/04; Cost $1,021,985)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.1315359477124183,
                "top": 0.4595959595959596,
                "width": 0.5359477124183006,
                "height": 0.008207070707070708,
                "page": 1,
                "original_page": 1
              },
              "content": "Saks, Inc. 2% 2024 cv. sr. notes (Ba3). (Acquired 03/17/04 - 04/23/04; Cost $1,021,985)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.4722222089767456,
                "width": 0.23366011679172516,
                "height": 0.008838385343551636,
                "page": 1,
                "original_page": null
              },
              "content": "and Loan -1.8% Banking/Savings",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,000,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04493464052287582,
                "top": 0.4595959595959596,
                "width": 0.0661764705882353,
                "height": 0.008207070707070708,
                "page": 1,
                "original_page": 1
              },
              "content": "1,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,009,950",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7581699346405228,
                "top": 0.4595959595959596,
                "width": 0.0661764705882353,
                "height": 0.008207070707070708,
                "page": 1,
                "original_page": 1
              },
              "content": "1,009,950",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "interest_rate_raw": {
          "value": "2%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.30800653594771243,
                "top": 0.4595959595959596,
                "width": 0.018790849673202614,
                "height": 0.008207070707070708,
                "page": 1,
                "original_page": 1
              },
              "content": "2%",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "maturity_date": {
          "value": "2024",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.36764705882352944,
                "top": 0.4595959595959596,
                "width": 0.02287581699346405,
                "height": 0.008207070707070708,
                "page": 1,
                "original_page": 1
              },
              "content": "2024",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "cost_raw": {
          "value": "$1,021,985",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.75,
                "top": 0.4595959595959596,
                "width": 0.07434640522875817,
                "height": 0.008207070707070708,
                "page": 1,
                "original_page": 1
              },
              "content": "$1,021,985",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(2)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.48856209150326796,
                  "top": 0.4595959595959596,
                  "width": 0.014705882352941176,
                  "height": 0.008207070707070708,
                  "page": 1,
                  "original_page": 1
                },
                "content": "(2)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Retail",
            "citations": []
          }
        ],
        "investment": {
          "value": "The TJX Companies, Inc. 0% 2021 LYONS (Baal)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13071895424836602,
                "top": 0.24873737373737373,
                "width": 0.43790849673202614,
                "height": 0.007575757575757576,
                "page": 1,
                "original_page": 1
              },
              "content": "The TJX Companies, Inc. 0% 2021 LYONS (Baal)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "quantity_raw": {
          "value": "2,400,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7573529411764706,
                "top": 0.24873737373737373,
                "width": 0.06699346405228758,
                "height": 0.007575757575757576,
                "page": 1,
                "original_page": 1
              },
              "content": "2,400,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "2,112,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.15604575163398693,
                "top": 0.24873737373737373,
                "width": 0.06535947712418301,
                "height": 0.007575757575757576,
                "page": 1,
                "original_page": 1
              },
              "content": "2,112,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "interest_rate_raw": {
          "value": "0%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.21486927568912506,
                "top": 0.42424243688583374,
                "width": 0.013888895511627197,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "0%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2021",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.40522876381874084,
                "top": 0.7683081030845642,
                "width": 0.028594762086868286,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "2021",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.31313130259513855,
                "width": 0.23529411852359772,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "Lamar Advertising Company 2.875%",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Retail",
            "citations": []
          }
        ],
        "label": {
          "value": "",
          "citations": [
            {
              "type": "Table",
              "bbox": {
                "left": 0.02696078431372549,
                "top": 0.22537878787878787,
                "width": 0.809640522875817,
                "height": 0.7209595959595959,
                "page": 1,
                "original_page": 7
              },
              "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "fair_value_raw": {
          "value": "9,091,513",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.758169949054718,
                "top": 0.3137626349925995,
                "width": 0.06535947322845459,
                "height": 0.006313115358352661,
                "page": 1,
                "original_page": null
              },
              "content": "1,078,125",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Technology",
            "citations": []
          }
        ],
        "investment": {
          "value": "Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13562092185020447,
                "top": 0.620580792427063,
                "width": 0.2736928164958954,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "(Acquired 04/22/04; Cost $999,375) (2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "1,500,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04493464052287582,
                "top": 0.6186868686868687,
                "width": 0.0661764705882353,
                "height": 0.008207070707070708,
                "page": 1,
                "original_page": 1
              },
              "content": "1,500,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,488,750",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7728758454322815,
                "top": 0.620580792427063,
                "width": 0.049836575984954834,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "883,750",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "4.25%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3611111044883728,
                "top": 0.8667929172515869,
                "width": 0.036764711141586304,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "4.25%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2007",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.33169934153556824,
                "top": 0.8554292917251587,
                "width": 0.028594762086868286,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "2007",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Technology",
            "citations": []
          }
        ],
        "investment": {
          "value": "Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.5347222089767456,
                "width": 0.39460785686969757,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "Church & Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "2,191,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04493464156985283,
                "top": 0.6584596037864685,
                "width": 0.06535947695374489,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "1,900,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "2,227,973",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7573529481887817,
                "top": 0.5347222089767456,
                "width": 0.06699347496032715,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "2,484,280",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "5.25%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3243463933467865,
                "top": 0.5347222089767456,
                "width": 0.036764711141586304,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "5.25%",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2006",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.36846405267715454,
                "top": 0.5347222089767456,
                "width": 0.028594762086868286,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "2033",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Technology",
            "citations": []
          }
        ],
        "investment": {
          "value": "Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13643790781497955,
                "top": 0.756313145160675,
                "width": 0.28839869797229767,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "(Acquired 04/22/04; Cost $1,265,000) (2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "2,378,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7589869499206543,
                "top": 0.7569444179534912,
                "width": 0.06535947322845459,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "1,270,313",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,331,680",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7589869499206543,
                "top": 0.7569444179534912,
                "width": 0.06535947322845459,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "1,270,313",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "0%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.21486927568912506,
                "top": 0.42424243688583374,
                "width": 0.013888895511627197,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "0%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2017",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.31781044602394104,
                "top": 0.756313145160675,
                "width": 0.0784313976764679,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "$1,265,000)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Technology",
            "citations": []
          }
        ],
        "investment": {
          "value": "International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.6079545617103577,
                "width": 0.40849675238132477,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "deb. Graftech International LTD 1.625% 2024 cv. sr. (B2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_raw": {
          "value": "2,000,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04411764815449715,
                "top": 0.5353535413742065,
                "width": 0.06617647036910057,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "2,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "2,002,500",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.758169949054718,
                "top": 0.7064393758773804,
                "width": 0.06535947322845459,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "1,201,563",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "4.25%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.3611111044883728,
                "top": 0.8667929172515869,
                "width": 0.036764711141586304,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "4.25%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2007",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.33169934153556824,
                "top": 0.8554292917251587,
                "width": 0.028594762086868286,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "2007",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.2589869201183319,
                "top": 0.7683081030845642,
                "width": 0.0506536066532135,
                "height": 0.00820702314376831,
                "page": 1,
                "original_page": null
              },
              "content": "Holding",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Technology",
            "citations": []
          }
        ],
        "investment": {
          "value": "STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3) (Acquired 07/29/03 - 12/22/03; Cost $2,067,500)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.5347222089767456,
                "width": 0.39460785686969757,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "Church & Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.1315359477124183,
                "top": 0.5460858585858586,
                "width": 0.5857843137254902,
                "height": 0.008207070707070708,
                "page": 1,
                "original_page": 1
              },
              "content": "STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3) (Acquired 07/29/03 - 12/22/03; Cost $2,067,500)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "quantity_raw": {
          "value": "2,000,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04411764815449715,
                "top": 0.5353535413742065,
                "width": 0.06617647036910057,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "2,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "quantity_type": {
          "value": "principal",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.22664141654968262,
                "width": 0.06617647223174572,
                "height": 0.008207067847251892,
                "page": 1,
                "original_page": null
              },
              "content": "Principal",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "fair_value_raw": {
          "value": "1,980,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.04411764815449715,
                "top": 0.5353535413742065,
                "width": 0.06617647036910057,
                "height": 0.006944417953491211,
                "page": 1,
                "original_page": null
              },
              "content": "2,000,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "interest_rate_raw": {
          "value": "0%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.21486927568912506,
                "top": 0.42424243688583374,
                "width": 0.013888895511627197,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "0%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "maturity_date": {
          "value": "2013",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.36846405267715454,
                "top": 0.5347222089767456,
                "width": 0.028594762086868286,
                "height": 0.008207082748413086,
                "page": 1,
                "original_page": null
              },
              "content": "2033",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "cost_raw": {
          "value": "$2,067,500",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7442810535430908,
                "top": 0.3137626349925995,
                "width": 0.07924836874008179,
                "height": 0.006313115358352661,
                "page": 1,
                "original_page": null
              },
              "content": "$ 1,078,125",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "footnote_markers": [
          {
            "value": "(2)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.46405228972435,
                  "top": 0.5347222089767456,
                  "width": 0.027777761220932007,
                  "height": 0.008207082748413086,
                  "page": 1,
                  "original_page": null
                },
                "content": "deb.",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null,
                "parentBlock": {
                  "type": "Table",
                  "bbox": {
                    "left": 0.02696078431372549,
                    "top": 0.22537878787878787,
                    "width": 0.809640522875817,
                    "height": 0.7209595959595959,
                    "page": 1,
                    "original_page": null
                  },
                  "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                  "image_url": null,
                  "chart_data": null,
                  "confidence": "low",
                  "granular_confidence": {
                    "extract_confidence": null,
                    "parse_confidence": 0.786067078744664
                  },
                  "extra": null
                }
              }
            ]
          },
          {
            "value": "(3)",
            "citations": [
              {
                "type": "Text",
                "bbox": {
                  "left": 0.5040849447250366,
                  "top": 0.5347222089767456,
                  "width": 0.023692846298217773,
                  "height": 0.008207082748413086,
                  "page": 1,
                  "original_page": null
                },
                "content": "(B1)",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null,
                "parentBlock": {
                  "type": "Table",
                  "bbox": {
                    "left": 0.02696078431372549,
                    "top": 0.22537878787878787,
                    "width": 0.809640522875817,
                    "height": 0.7209595959595959,
                    "page": 1,
                    "original_page": null
                  },
                  "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                  "image_url": null,
                  "chart_data": null,
                  "confidence": "low",
                  "granular_confidence": {
                    "extract_confidence": null,
                    "parse_confidence": 0.786067078744664
                  },
                  "extra": null
                }
              }
            ]
          }
        ]
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13562092185020447,
                "top": 0.9286616444587708,
                "width": 0.06372548639774323,
                "height": 0.0075757503509521484,
                "page": 1,
                "original_page": null
              },
              "content": "(Acquired",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          },
          {
            "value": "Technology",
            "citations": []
          }
        ],
        "label": {
          "value": "",
          "citations": [
            {
              "type": "Table",
              "bbox": {
                "left": 0.02696078431372549,
                "top": 0.22537878787878787,
                "width": 0.809640522875817,
                "height": 0.7209595959595959,
                "page": 1,
                "original_page": 7
              },
              "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null
            }
          ]
        },
        "fair_value_raw": {
          "value": "9,030,903",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.758169949054718,
                "top": 0.9292929172515869,
                "width": 0.06617647409439087,
                "height": 0.006944477558135986,
                "page": 1,
                "original_page": null
              },
              "content": "1,095,938",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.786067078744664
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02696078431372549,
                  "top": 0.22537878787878787,
                  "width": 0.809640522875817,
                  "height": 0.7209595959595959,
                  "page": 1,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1).</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- 53.6%</td><td> </td></tr><tr><td> </td><td>Advertising -- 0.9%</td><td> </td></tr><tr><td>$ 1,000,000</td><td>Lamar Advertising Company 2.875% 2010 cv. sub. notes. (B2)</td><td>$ 1,078,125</td></tr><tr><td> </td><td>Aerospace and Defense - 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>The Goldman Sachs Group, Inc. 1% 2009 exch. equity-linked notes (Aa3)\n(exch. for General Dynamics Corp. common stock) (1)</td><td>1,438,740</td></tr><tr><td> </td><td>Automotive -- 2.5%</td><td> </td></tr><tr><td>1,000,000</td><td>American Axle &amp; Manufacturing Holdings, Inc. 2% 2024 cv. sr. notes. (Baa3)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/06/04 - 02/12/04; Cost $1,044,500) (1) (2)</td><td>1,010,625</td></tr><tr><td>3,500,000</td><td>Lear Corp. 0% 2022 cv. sr. notes (Bal)</td><td>1,826,563</td></tr><tr><td> </td><td> </td><td>2,837,188</td></tr><tr><td> </td><td>Banking/Savings and Loan -1.8%</td><td> </td></tr><tr><td>2,078,000</td><td>The Bear Stearns Companies, Inc. 0.25% 2010 medium term notes (A1)\n(exch. for Fifth Third Bancorp common stock) (1)</td><td>2,059,714</td></tr><tr><td> </td><td>Consumer Goods 2.28</td><td> </td></tr><tr><td>2,000,000</td><td>Church &amp; Dwight Co., Inc. 5.25% 2033 cv. sr. deb. (B1)</td><td>2,484,280</td></tr><tr><td> </td><td>Data Processing Services -- 1.2%</td><td> </td></tr><tr><td>1,500,000</td><td>Pegasus Solutions, Inc. 3.875% 2023 cv. sr. notes (NR)</td><td>1,387,500</td></tr><tr><td> </td><td>Electrical Supplies -- 0.8%</td><td> </td></tr><tr><td>1,000,000</td><td>Graftech International LTD 1.625% 2024 cv. sr. deb. (B2)\n(Acquired 04/22/04; Cost $999,375) (2)</td><td>883,750</td></tr><tr><td> </td><td>Energy 1.7%</td><td> </td></tr><tr><td>1,900,000</td><td>Kerr-McGee Corp. 5.25% 2010 cv. sub. deb. (Baa3)</td><td>2,006,457</td></tr><tr><td> </td><td>Entertainment -- 1.08</td><td> </td></tr><tr><td>1,250,000</td><td>Citadel Broadcasting Corp. 1.875% 2011 cv. sub. notes. (NR)\n(Acquired 02/11/04 - 02/25/04; Cost $1,246,250) (2)</td><td>1,201,563</td></tr><tr><td> </td><td>Financial and Insurance - 1.98</td><td> </td></tr><tr><td>1,250,000</td><td>Leucadia National Corp. 3.75% 2014 cv. sr. sub. notes (Ba3)\n(Acquired 04/22/04; Cost $1,265,000) (2)</td><td>1,270,313</td></tr><tr><td>1,000,000</td><td>Swiss Re America Holding Corp. 3.25% 2021 euro. sub. cv. bonds (Aal)\n(conv. into Swiss Reinsurance Company common stock) (Acquired 11/15/01 -\n12/05/01; Cost $1,007,750) (2)</td><td>945,625</td></tr><tr><td> </td><td> </td><td>2,215,938</td></tr><tr><td> </td><td>Health Care -- 3.4%</td><td> </td></tr><tr><td>1,000,000</td><td>AmerisourceBergen Corp. 5% 2007 cv. sub. notes (B1)</td><td>1,177,950</td></tr><tr><td>1,000,000</td><td>Community Health Systems, Inc. 4.25% 2008 cv. sub. notes (B3)</td><td>1,064,100</td></tr><tr><td>500,000</td><td>LifePoint Hospitals, Inc. 4.50% 2009 cv. sub. notes (B3)</td><td>525,000</td></tr><tr><td>125,000</td><td>Matria Healthcare, Inc. 4.875% 2024 cv. sr. sub. notes (NR)\n(Acquired 04/30/04; Cost $125,000) (2)</td><td>126,094</td></tr><tr><td>875,000</td><td>Mentor Corp. 2.75% 2024 cv. sub. notes (NR).</td><td> </td></tr><tr><td> </td><td>(Acquired 12/17/03 - 01/30/04; Cost $941,250) (2)</td><td>1,095,938</td></tr><tr><th>Principal\nAmount</th><th> </th><th>Value\n(Note 1)</th></tr><tr><td> </td><td>CONVERTIBLE BONDS AND NOTES -- (continued)</td><td> </td></tr><tr><td> </td><td>Office Equipment -- 1.6%</td><td> </td></tr><tr><td>$ 1,750,000</td><td>IOS Capital, LLC 5% 2007 cv. sub. notes (Ba3) (exch. for IKON Office Solutions,\nInc. common stock) (Acquired 05/08/02 - 06/02/03; Cost $1,746,250) (2)</td><td>$ 1,828,750</td></tr><tr><td> </td><td>Pharmaceuticals -- 10.2%</td><td> </td></tr><tr><td>2,000,000</td><td>Alza Corp. 0% 2020 cv. sub. deb. (Aal)</td><td> </td></tr><tr><td> </td><td>(exch. for Johnson &amp; Johnson common stock)</td><td>1,507,500</td></tr><tr><td>2,000,000</td><td>Amgen, Inc. 0% 2032 LYONS (A2) (1)</td><td>1,478,973</td></tr><tr><td>1,250,000</td><td>Gilead Sciences, Inc. 2% 2007 cv. sr. notes (NR)</td><td>1,744,531</td></tr><tr><td>1,125,000</td><td>Impax Laboratories, Inc. 1.25% 2024 cv. sr. sub. deb. (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 03/31/04 - 04/23/04; Cost $1,208,750) (2)</td><td>1,157,614</td></tr><tr><td>500,000</td><td>Ivax Corp. 4.50% 2008 cv. sr. sub. notes (NR)</td><td>506,250</td></tr><tr><td>1,250,000</td><td>Ivax Corp. 1.50% 2024 cv. sr. notes (NR)</td><td> </td></tr><tr><td> </td><td>(Acquired 02/27/04; Cost $1,262,103) (1) (2)</td><td>1,233,088</td></tr><tr><td>1,050,000</td><td>Medarex, Inc. 2.25% 2011 cv. sr. notes (NR)\n(Acquired 04/27/04 - 04/28/04; Cost $1,055,000) (2)</td><td>1,031,625</td></tr><tr><td>750,000</td><td>Teva Pharmaceutical Finance B.V. 0.75% 2021 cv. sub. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,085,250</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series A 0.50% 2024 cv. sr. deb. (BBB)\n(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,010,000</td></tr><tr><td>1,000,000</td><td>Teva Pharmaceutical Finance II, LLC series B 0.25% 2024 cv. sr. deb. (BBB)</td><td> </td></tr><tr><td> </td><td>(exch. for ADR representing Teva Pharmaceuticals Industries Ltd. common stock)</td><td>1,018,750</td></tr><tr><td> </td><td> </td><td>11,773,581</td></tr><tr><td> </td><td>Retail 7.98</td><td> </td></tr><tr><td>1,300,000</td><td>Dick's Sporting Goods, Inc. 1.6061% 2024 sr. cv. notes (NR)\n(Acquired 02/11/04 - 03/15/04; Cost $917,772) (2)</td><td>882,375</td></tr><tr><td>1,000,000</td><td>Casual Male Retail Group, Inc. 5% 2024 cv. sr. sub. notes (NR)\n(Acquired 11/13/03 - 12/19/03; Cost $1,015,985) (2)</td><td>1,165,000</td></tr><tr><td>1,500,000</td><td>Charming Shoppes, Inc. 4.75% 2012 sr. cv. notes (B2)</td><td>1,629,375</td></tr><tr><td>1,500,000</td><td>Costco Wholesale Corp. 0% 2017 cv. sub. notes (A3)</td><td>1,289,063</td></tr><tr><td>1,000,000</td><td>Reebok International Ltd. 2% 2024 cv. deb. (BBB)\n(Acquired 04/27/04; Cost $1,004,375) (1) (2)</td><td>1,003,750</td></tr><tr><td>1,000,000</td><td>Saks, Inc. 2% 2024 cv. sr. notes (Ba3).</td><td> </td></tr><tr><td> </td><td>(Acquired 03/17/04 - 04/23/04; Cost $1,021,985) (2)</td><td>1,009,950</td></tr><tr><td>2,400,000</td><td>The TJX Companies, Inc. 0% 2021 LYONS (Baal)</td><td>2,112,000</td></tr><tr><td> </td><td> </td><td>9,091,513</td></tr><tr><td> </td><td>Technology -- 7.8%</td><td> </td></tr><tr><td>1,500,000</td><td>Axcelis Technologies, Inc. 4.25% 2007 cv. sub. notes (NR)</td><td>1,488,750</td></tr><tr><td>2,191,000</td><td>Conexant Systems, Inc. 5.25% 2006 cv. sub. notes (NR)</td><td>2,227,973</td></tr><tr><td>2,378,000</td><td>Hewlett-Packard Co., Inc. 0% 2017 LYONS (Baal)</td><td>1,331,680</td></tr><tr><td>2,000,000</td><td>International Rectifier Corp. 4.25% 2007 cv. sub. notes (B2)</td><td>2,002,500</td></tr><tr><td>2,000,000</td><td>STMicroelectronics, N.V. 0% 2013 sr. cv. bonds (A3)</td><td> </td></tr><tr><td> </td><td>(Acquired 07/29/03 - 12/22/03; Cost $2,067,500) (2) (3)</td><td>1,980,000</td></tr><tr><td> </td><td> </td><td>9,030,903</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.786067078744664
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          }
        ],
        "investment": {
          "value": "Principal Amount: $1,500,000",
          "citations": []
        },
        "quantity_raw": {
          "value": "$1,500,000",
          "citations": []
        },
        "quantity_type": {
          "value": "principal",
          "citations": []
        },
        "fair_value_raw": {
          "value": "$ 1,706,250",
          "citations": []
        },
        "row_text": {
          "value": "Principal Amount: $1,500,000\nValue (Note 1): $ 1,706,250",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.03758169934640523,
                "top": 0.11616161616161616,
                "width": 0.7785947712418301,
                "height": 0.09154040404040405,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: $1,500,000\nValue (Note 1): $ 1,706,250",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          }
        ],
        "investment": {
          "value": "Principal Amount: 1,000,000",
          "citations": []
        },
        "quantity_raw": {
          "value": "1,000,000",
          "citations": []
        },
        "quantity_type": {
          "value": "principal",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,293,340",
          "citations": []
        },
        "row_text": {
          "value": "Principal Amount: 1,000,000\nValue (Note 1): 1,293,340",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.0457516339869281,
                "top": 0.11616161616161616,
                "width": 0.7704248366013072,
                "height": 0.00946969696969697,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 1,000,000\nValue (Note 1): 1,293,340",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          }
        ],
        "investment": {
          "value": "Principal Amount: 500,000",
          "citations": []
        },
        "quantity_raw": {
          "value": "500,000",
          "citations": []
        },
        "quantity_type": {
          "value": "principal",
          "citations": []
        },
        "fair_value_raw": {
          "value": "674,950",
          "citations": []
        },
        "row_text": {
          "value": "Principal Amount: 500,000\nValue (Note 1): 674,950",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.03758169934640523,
                "top": 0.1994949494949495,
                "width": 0.7785947712418301,
                "height": 0.011363636363636364,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 500,000\nValue (Note 1): 674,950",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.03758169934640523,
                "top": 0.22474747474747475,
                "width": 0.0727124183006536,
                "height": 0.008838383838383838,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 500,000\nValue (Note 1): 674,950",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.06045751633986928,
                "top": 0.2380050505050505,
                "width": 0.049836601307189546,
                "height": 0.008207070707070708,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 500,000\nValue (Note 1): 674,950",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.7524509803921569,
                "top": 0.22474747474747475,
                "width": 0.06372549019607843,
                "height": 0.00946969696969697,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 500,000\nValue (Note 1): 674,950",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          }
        ],
        "investment": {
          "value": "Principal Amount: 500,000",
          "citations": []
        },
        "quantity_raw": {
          "value": "500,000",
          "citations": []
        },
        "quantity_type": {
          "value": "principal",
          "citations": []
        },
        "fair_value_raw": {
          "value": "519,369",
          "citations": []
        },
        "row_text": {
          "value": "Principal Amount: 500,000\nValue (Note 1): 519,369",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.0457516339869281,
                "top": 0.20075757575757575,
                "width": 0.7704248366013072,
                "height": 0.010101010101010102,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 500,000\nValue (Note 1): 519,369",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.0457516339869281,
                "top": 0.22411616161616163,
                "width": 0.06454248366013073,
                "height": 0.008207070707070708,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 500,000\nValue (Note 1): 519,369",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.7655228758169934,
                "top": 0.24936868686868688,
                "width": 0.05065359477124183,
                "height": 0.008838383838383838,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 500,000\nValue (Note 1): 519,369",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          }
        ],
        "investment": {
          "value": "Principal Amount: 1,250,000",
          "citations": []
        },
        "quantity_raw": {
          "value": "1,250,000",
          "citations": []
        },
        "quantity_type": {
          "value": "principal",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,176,563",
          "citations": []
        },
        "row_text": {
          "value": "Principal Amount: 1,250,000\nValue (Note 1): 1,176,563",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.0457516339869281,
                "top": 0.26262626262626265,
                "width": 0.06454248366013073,
                "height": 0.006944444444444444,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 1,250,000\nValue (Note 1): 1,176,563",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.1315359477124183,
                "top": 0.26262626262626265,
                "width": 0.34477124183006536,
                "height": 0.006944444444444444,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 1,250,000\nValue (Note 1): 1,176,563",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.7328431372549019,
                "top": 0.26262626262626265,
                "width": 0.08333333333333333,
                "height": 0.006944444444444444,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 1,250,000\nValue (Note 1): 1,176,563",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          }
        ],
        "investment": {
          "value": "Principal Amount: 1,250,000",
          "citations": []
        },
        "quantity_raw": {
          "value": "1,250,000",
          "citations": []
        },
        "quantity_type": {
          "value": "principal",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,490,625",
          "citations": []
        },
        "row_text": {
          "value": "Principal Amount: 1,250,000\nValue (Note 1): 1,490,625",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.0457516339869281,
                "top": 0.2619949494949495,
                "width": 0.06535947712418301,
                "height": 0.007575757575757576,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 1,250,000\nValue (Note 1): 1,490,625",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.1315359477124183,
                "top": 0.2619949494949495,
                "width": 0.34477124183006536,
                "height": 0.007575757575757576,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 1,250,000\nValue (Note 1): 1,490,625",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.7303921568627451,
                "top": 0.2619949494949495,
                "width": 0.0857843137254902,
                "height": 0.007575757575757576,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 1,250,000\nValue (Note 1): 1,490,625",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          }
        ],
        "investment": {
          "value": "Principal Amount: 1,000,000",
          "citations": []
        },
        "quantity_raw": {
          "value": "1,000,000",
          "citations": []
        },
        "quantity_type": {
          "value": "principal",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,308,750",
          "citations": []
        },
        "row_text": {
          "value": "Principal Amount: 1,000,000\nValue (Note 1): 1,308,750",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.03758169934640523,
                "top": 0.11616161616161616,
                "width": 0.7785947712418301,
                "height": 0.015782828282828284,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 1,000,000\nValue (Note 1): 1,308,750",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          }
        ],
        "investment": {
          "value": "Principal Amount:",
          "citations": []
        },
        "quantity_raw": {
          "value": null,
          "citations": []
        },
        "quantity_type": {
          "value": "principal",
          "citations": []
        },
        "fair_value_raw": {
          "value": "8,169,847",
          "citations": []
        },
        "row_text": {
          "value": "Principal Amount: \nValue (Note 1): 8,169,847",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.0457516339869281,
                "top": 0.11616161616161616,
                "width": 0.7491830065359477,
                "height": 0.2032828282828283,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: \nValue (Note 1): 8,169,847",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          }
        ],
        "investment": {
          "value": "Principal Amount: 500,000",
          "citations": []
        },
        "quantity_raw": {
          "value": "500,000",
          "citations": []
        },
        "quantity_type": {
          "value": "principal",
          "citations": []
        },
        "fair_value_raw": {
          "value": "510,480",
          "citations": []
        },
        "row_text": {
          "value": "Principal Amount: 500,000\nValue (Note 1): 510,480",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.042483660130718956,
                "top": 0.19886363636363635,
                "width": 0.06781045751633986,
                "height": 0.007575757575757576,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 500,000\nValue (Note 1): 510,480",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.042483660130718956,
                "top": 0.22474747474747475,
                "width": 0.06781045751633986,
                "height": 0.007575757575757576,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 500,000\nValue (Note 1): 510,480",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.042483660130718956,
                "top": 0.2380050505050505,
                "width": 0.06781045751633986,
                "height": 0.007575757575757576,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 500,000\nValue (Note 1): 510,480",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.7655228758169934,
                "top": 0.34785353535353536,
                "width": 0.049836601307189546,
                "height": 0.007575757575757576,
                "page": 3,
                "original_page": 3
              },
              "content": "Principal Amount: 500,000\nValue (Note 1): 510,480",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "TOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE BONDS AND NOTES",
            "citations": []
          }
        ],
        "label": {
          "value": "TOTAL CONVERTIBLE BONDS AND NOTES",
          "citations": []
        },
        "fair_value_raw": {
          "value": "61,987,411",
          "citations": []
        },
        "row_text": {
          "value": "TOTAL CONVERTIBLE BONDS AND NOTES\nPrincipal Amount: \nValue (Note 1): 61,987,411",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.1315359477124183,
                "top": 0.3731060606060606,
                "width": 0.2434640522875817,
                "height": 0.008207070707070708,
                "page": 3,
                "original_page": 3
              },
              "content": "TOTAL CONVERTIBLE BONDS AND NOTES\nPrincipal Amount: \nValue (Note 1): 61,987,411",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.7051382154226302
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          }
        ],
        "label": {
          "value": "CONVERTIBLE PREFERRED STOCKS -- 20.2%",
          "citations": []
        },
        "row_text": {
          "value": "CONVERTIBLE PREFERRED STOCKS -- 20.2%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.4362373650074005,
                "width": 0.27124182879924774,
                "height": 0.006313145160675049,
                "page": 3,
                "original_page": null
              },
              "content": "CONVERTIBLE PREFERRED STOCKS -- 20.2%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Automotive",
            "citations": []
          }
        ],
        "label": {
          "value": "Automotive - 1.38",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "1.38",
          "citations": []
        },
        "row_text": {
          "value": "Automotive - 1.38",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13235294818878174,
                "top": 0.4595959484577179,
                "width": 0.13153594732284546,
                "height": 0.007575780153274536,
                "page": 3,
                "original_page": null
              },
              "content": "Automotive - 1.38",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Automotive",
            "citations": []
          }
        ],
        "investment": {
          "value": "General Motors Corp. 6.25% series C cv. sr. deb. (Baal)",
          "citations": []
        },
        "quantity_raw": {
          "value": "50,000",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,515,625",
          "citations": []
        },
        "row_text": {
          "value": "50,000 General Motors Corp. 6.25% series C cv. sr. deb. (Baal) 1,515,625",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.06699346750974655,
                "top": 0.47285354137420654,
                "width": 0.7500000074505806,
                "height": 0.008207052946090698,
                "page": 3,
                "original_page": null
              },
              "content": "50,000 General Motors Corp. 6.25% series C cv. sr. deb. (Baal) 1,515,625",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Banking/Savings and Loan",
            "citations": []
          }
        ],
        "label": {
          "value": "Banking/Savings and Loan -- 8.2%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "8.2%",
          "citations": []
        },
        "row_text": {
          "value": "Banking/Savings and Loan -- 8.2%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.4968434274196625,
                "width": 0.23447711765766144,
                "height": 0.008838385343551636,
                "page": 3,
                "original_page": null
              },
              "content": "-- 8.2% Banking/Savings and Loan",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Banking/Savings and Loan",
            "citations": []
          }
        ],
        "investment": {
          "value": "Commerce Capital Trust II 5.95% cv. trust pfd. (Baal) (exch. for Commerce Bancorp, Inc. common stock)",
          "citations": []
        },
        "quantity_raw": {
          "value": "20,000",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,237,500",
          "citations": []
        },
        "row_text": {
          "value": "20,000 Commerce Capital Trust II 5.95% cv. trust pfd. (Baal) (exch. for Commerce Bancorp, Inc. common stock) 1,237,500",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.06699346750974655,
                "top": 0.5094696879386902,
                "width": 0.7500000074505806,
                "height": 0.020202040672302246,
                "page": 3,
                "original_page": null
              },
              "content": "20,000 Commerce Capital Trust II 5.95% cv. trust pfd. (Baal) 1,237,500 (exch. for Commerce Bancorp, Inc. common stock)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Banking/Savings and Loan",
            "citations": []
          }
        ],
        "investment": {
          "value": "National Australia Bank Ltd. 7.875% exch. capital units (NR)",
          "citations": []
        },
        "quantity_raw": {
          "value": "40,000",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,436,400",
          "citations": []
        },
        "row_text": {
          "value": "40,000 National Australia Bank Ltd. 7.875% exch. capital units (NR) 1,436,400",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.06699346750974655,
                "top": 0.5340909361839294,
                "width": 0.7500000074505806,
                "height": 0.0075757503509521484,
                "page": 3,
                "original_page": null
              },
              "content": "40,000 National Australia Bank Ltd. 7.875% exch. capital units (NR) 1,436,400",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Banking/Savings and Loan",
            "citations": []
          }
        ],
        "investment": {
          "value": "New York Community Bancorp, Inc. 6% BONUSES units (Baa2)",
          "citations": []
        },
        "quantity_raw": {
          "value": "30,000",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,987,500",
          "citations": []
        },
        "row_text": {
          "value": "30,000 New York Community Bancorp, Inc. 6% BONUSES units (Baa2) 1,987,500",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.06781046092510223,
                "top": 0.5467171669006348,
                "width": 0.7491830140352249,
                "height": 0.008207082748413086,
                "page": 3,
                "original_page": null
              },
              "content": "30,000 New York Community Bancorp, Inc. 6% BONUSES units (Baa2) 1,987,500",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Banking/Savings and Loan",
            "citations": []
          }
        ],
        "investment": {
          "value": "Sovereign Capital Trust IV 4.375% PIERS (Bal) (exch. for Sovereign Bancorp, Inc. common stock)",
          "citations": []
        },
        "quantity_raw": {
          "value": "50,000",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "2,350,000",
          "citations": []
        },
        "footnote_markers": [
          {
            "value": "(1)",
            "citations": []
          }
        ],
        "row_text": {
          "value": "50,000 Sovereign Capital Trust IV 4.375% PIERS (Bal) (exch. for Sovereign Bancorp, Inc. common stock) (1) 2,350,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.06781046092510223,
                "top": 0.5587121248245239,
                "width": 0.3937908560037613,
                "height": 0.008207082748413086,
                "page": 3,
                "original_page": null
              },
              "content": "Sovereign Capital Trust IV 4.375% PIERS (Bal) 50,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.5587121248245239,
                "width": 0.3284313827753067,
                "height": 0.008207082748413086,
                "page": 3,
                "original_page": null
              },
              "content": "Sovereign Capital Trust IV 4.375% PIERS (Bal)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.5587121248245239,
                "width": 0.3284313827753067,
                "height": 0.008207082748413086,
                "page": 3,
                "original_page": null
              },
              "content": "Sovereign Capital Trust IV 4.375% PIERS (Bal)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Banking/Savings and Loan",
            "citations": []
          }
        ],
        "investment": {
          "value": "Washington Mutual Capital Trust PIERS units (Baal) (exch. for Washington Mutual, Inc. common stock)",
          "citations": []
        },
        "quantity_raw": {
          "value": "45,000",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "2,486,250",
          "citations": []
        },
        "row_text": {
          "value": "45,000 Washington Mutual Capital Trust PIERS units (Baal) (exch. for Washington Mutual, Inc. common stock) 2,486,250",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.06699346750974655,
                "top": 0.5833333134651184,
                "width": 0.043300651013851166,
                "height": 0.0075757503509521484,
                "page": 3,
                "original_page": null
              },
              "content": "45,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.13235294818878174,
                "top": 0.5833333134651184,
                "width": 0.3660130500793457,
                "height": 0.0075757503509521484,
                "page": 3,
                "original_page": null
              },
              "content": "Washington Mutual Capital Trust PIERS units (Baal)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.13235294818878174,
                "top": 0.5833333134651184,
                "width": 0.3660130500793457,
                "height": 0.020202040672302246,
                "page": 3,
                "original_page": null
              },
              "content": "Washington Mutual Capital Trust PIERS units (Baal) (exch. for Washington Mutual, Inc. common stock)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Banking/Savings and Loan",
            "citations": []
          }
        ],
        "label": {
          "value": "Banking/Savings and Loan Total",
          "citations": []
        },
        "fair_value_raw": {
          "value": "9,497,650",
          "citations": []
        },
        "row_text": {
          "value": "9,497,650",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7508170008659363,
                "top": 0.620580792427063,
                "width": 0.06454247236251831,
                "height": 0.0075757503509521484,
                "page": 3,
                "original_page": null
              },
              "content": "9,497,650",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Energy",
            "citations": []
          }
        ],
        "label": {
          "value": "Energy 2.9%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "2.9%",
          "citations": []
        },
        "row_text": {
          "value": "Energy 2.9%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13235294818878174,
                "top": 0.6445707082748413,
                "width": 0.10294117033481598,
                "height": 0.008838355541229248,
                "page": 3,
                "original_page": null
              },
              "content": "2.9% Energy",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Energy",
            "citations": []
          }
        ],
        "investment": {
          "value": "Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)",
          "citations": []
        },
        "quantity_raw": {
          "value": "12,500",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "942,972",
          "citations": []
        },
        "row_text": {
          "value": "12,500 Chesapeake Energy Corp. 6% cum. cv. pfd. (B3) 942,972",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.06781046092510223,
                "top": 0.6578282713890076,
                "width": 0.7483660131692886,
                "height": 0.0075757503509521484,
                "page": 3,
                "original_page": null
              },
              "content": "12,500 Chesapeake Energy Corp. 6% cum. cv. pfd. (B3) 942,972",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Energy",
            "citations": []
          }
        ],
        "investment": {
          "value": "Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)",
          "citations": []
        },
        "quantity_raw": {
          "value": "1,000",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "cost_raw": {
          "value": "$1,000,000",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,048,750",
          "citations": []
        },
        "footnote_markers": [
          {
            "value": "(2)",
            "citations": []
          }
        ],
        "row_text": {
          "value": "1,000 Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3) (Acquired 03/24/04; Cost $1,000,000) (2) 1,048,750",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.07516340166330338,
                "top": 0.6698232293128967,
                "width": 0.035947710275650024,
                "height": 0.006944417953491211,
                "page": 3,
                "original_page": null
              },
              "content": "1,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Energy",
            "citations": []
          }
        ],
        "investment": {
          "value": "The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)",
          "citations": []
        },
        "quantity_raw": {
          "value": "20,000",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,347,500",
          "citations": []
        },
        "row_text": {
          "value": "20,000 The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-) 1,347,500",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.06699346750974655,
                "top": 0.6944444179534912,
                "width": 0.7500000074505806,
                "height": 0.008207082748413086,
                "page": 3,
                "original_page": null
              },
              "content": "20,000 The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-) 1,347,500",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Energy",
            "citations": []
          }
        ],
        "label": {
          "value": "Energy Total",
          "citations": []
        },
        "fair_value_raw": {
          "value": "3,339,222",
          "citations": []
        },
        "row_text": {
          "value": "3,339,222",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7508170008659363,
                "top": 0.7190656661987305,
                "width": 0.06454247236251831,
                "height": 0.0075757503509521484,
                "page": 3,
                "original_page": null
              },
              "content": "3,339,222",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Entertainment",
            "citations": []
          }
        ],
        "label": {
          "value": "Entertainment -2.3%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "2.3%",
          "citations": []
        },
        "row_text": {
          "value": "Entertainment -2.3%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.7430555820465088,
                "width": 0.1527777761220932,
                "height": 0.00820702314376831,
                "page": 3,
                "original_page": null
              },
              "content": "-2.3% Entertainment",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Entertainment",
            "citations": []
          }
        ],
        "investment": {
          "value": "Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)",
          "citations": []
        },
        "quantity_raw": {
          "value": "22,500",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,065,938",
          "citations": []
        },
        "row_text": {
          "value": "22,500 Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal) 1,065,938",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.06617647409439087,
                "top": 0.7550504803657532,
                "width": 0.7491829991340637,
                "height": 0.009469747543334961,
                "page": 3,
                "original_page": null
              },
              "content": "(Caal) 22,500 Emmis Communications Corp. 6.25% series A cum. pfd. 1,065,938 cv.",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Entertainment",
            "citations": []
          }
        ],
        "investment": {
          "value": "Radio One, Inc. 6.50% HIGH TIDES (B3)",
          "citations": []
        },
        "quantity_raw": {
          "value": "1,500",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,615,500",
          "citations": []
        },
        "row_text": {
          "value": "1,500 Radio One, Inc. 6.50% HIGH TIDES (B3) 1,615,500",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.07434640824794769,
                "top": 0.7676767706871033,
                "width": 0.7426470667123795,
                "height": 0.008207082748413086,
                "page": 3,
                "original_page": null
              },
              "content": "1,500 Radio One, Inc. 6.50% HIGH TIDES (B3) 1,615,500",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Entertainment",
            "citations": []
          }
        ],
        "label": {
          "value": "Entertainment Total",
          "citations": []
        },
        "fair_value_raw": {
          "value": "2,681,438",
          "citations": []
        },
        "row_text": {
          "value": "2,681,438",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7508170008659363,
                "top": 0.7929292917251587,
                "width": 0.06454247236251831,
                "height": 0.006944417953491211,
                "page": 3,
                "original_page": null
              },
              "content": "2,681,438",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Financial and Insurance",
            "citations": []
          }
        ],
        "label": {
          "value": "Financial and Insurance - 3.1%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "3.1%",
          "citations": []
        },
        "row_text": {
          "value": "Financial and Insurance - 3.1%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.8175504803657532,
                "width": 0.2271241694688797,
                "height": 0.006944477558135986,
                "page": 3,
                "original_page": null
              },
              "content": "Financial and Insurance - 3.1%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Financial and Insurance",
            "citations": []
          }
        ],
        "investment": {
          "value": "Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)",
          "citations": []
        },
        "quantity_raw": {
          "value": "20,000",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,148,500",
          "citations": []
        },
        "row_text": {
          "value": "20,000 Reinsurance Group of America, Inc. 5.75% PIERS (Baa2) 1,148,500",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.06699346750974655,
                "top": 0.8289141654968262,
                "width": 0.748366005718708,
                "height": 0.008838355541229248,
                "page": 3,
                "original_page": null
              },
              "content": "20,000 1,148,500 Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Financial and Insurance",
            "citations": []
          }
        ],
        "investment": {
          "value": "The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)",
          "citations": []
        },
        "quantity_raw": {
          "value": "100,000",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "2,457,000",
          "citations": []
        },
        "row_text": {
          "value": "100,000 The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal) 2,457,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.060457516461610794,
                "top": 0.8428030014038086,
                "width": 0.050653595477342606,
                "height": 0.006313145160675049,
                "page": 3,
                "original_page": null
              },
              "content": "100,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.8421717286109924,
                "width": 0.5490195900201797,
                "height": 0.008207082748413086,
                "page": 3,
                "original_page": null
              },
              "content": "The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.75,
                "top": 0.8421717286109924,
                "width": 0.06617647409439087,
                "height": 0.006944417953491211,
                "page": 3,
                "original_page": null
              },
              "content": "2,457,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Financial and Insurance",
            "citations": []
          }
        ],
        "label": {
          "value": "Financial and Insurance Total",
          "citations": []
        },
        "fair_value_raw": {
          "value": "3,605,500",
          "citations": []
        },
        "row_text": {
          "value": "3,605,500",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7508170008659363,
                "top": 0.8667929172515869,
                "width": 0.06617647409439087,
                "height": 0.006944477558135986,
                "page": 3,
                "original_page": null
              },
              "content": "3,605,500",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Health Care",
            "citations": []
          }
        ],
        "label": {
          "value": "Health Care -- 1.68",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "1.68",
          "citations": []
        },
        "row_text": {
          "value": "Health Care -- 1.68",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993415355682,
                "top": 0.8907828330993652,
                "width": 0.138888880610466,
                "height": 0.0075757503509521484,
                "page": 3,
                "original_page": null
              },
              "content": "Health Care -- 1.68",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Health Care",
            "citations": []
          }
        ],
        "investment": {
          "value": "Omnicare Capital Trust I 4% PIERS (Ba3) (exch. for Omnicare, Inc. common stock)",
          "citations": []
        },
        "quantity_raw": {
          "value": "29,000",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,798,000",
          "citations": []
        },
        "footnote_markers": [
          {
            "value": "(1)",
            "citations": []
          }
        ],
        "row_text": {
          "value": "29,000 Omnicare Capital Trust I 4% PIERS (Ba3) (exch. for Omnicare, Inc. common stock) (1) 1,798,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.06699346750974655,
                "top": 0.9034090638160706,
                "width": 0.7500000074505806,
                "height": 0.020202040672302246,
                "page": 3,
                "original_page": null
              },
              "content": "29,000 Omnicare Capital Trust I 4% PIERS (Ba3) (exch. for Omnicare, Inc. common stock) 1,798,000 (1)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Mining",
            "citations": []
          }
        ],
        "label": {
          "value": "Mining 0.8%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "0.8%",
          "citations": []
        },
        "row_text": {
          "value": "Mining 0.8%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13235294818878174,
                "top": 0.939393937587738,
                "width": 0.10294117033481598,
                "height": 0.009469687938690186,
                "page": 3,
                "original_page": null
              },
              "content": "0.8% Mining",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          },
          {
            "value": "Mining",
            "citations": []
          }
        ],
        "investment": {
          "value": "Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)",
          "citations": []
        },
        "quantity_raw": {
          "value": "1,000",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "882,750",
          "citations": []
        },
        "row_text": {
          "value": "1,000 Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC) 882,750",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.07516340166330338,
                "top": 0.9520202279090881,
                "width": 0.7410130724310875,
                "height": 0.00820702314376831,
                "page": 3,
                "original_page": null
              },
              "content": "882,750 1,000 Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.5921769312312526
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.05800653594771242,
                  "top": 0.432449494949495,
                  "width": 0.7630718954248366,
                  "height": 0.5296717171717171,
                  "page": 3,
                  "original_page": null
                },
                "content": "<table><tr><th colspan=\"3\">CONVERTIBLE PREFERRED STOCKS -- 20.2%</th></tr><tr><td></td><td>Automotive - 1.38</td><td></td></tr><tr><td>50,000</td><td>General Motors Corp. 6.25% series C cv. sr. deb. (Baal)</td><td>1,515,625</td></tr><tr><td></td><td>Banking/Savings and Loan -- 8.2%</td><td></td></tr><tr><td>20,000</td><td>Commerce Capital Trust II 5.95% cv. trust pfd. (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Commerce Bancorp, Inc. common stock)</td><td>1,237,500</td></tr><tr><td>40,000</td><td>National Australia Bank Ltd. 7.875% exch. capital units (NR)</td><td>1,436,400</td></tr><tr><td>30,000</td><td>New York Community Bancorp, Inc. 6% BONUSES units (Baa2)</td><td>1,987,500</td></tr><tr><td>50,000</td><td>Sovereign Capital Trust IV 4.375% PIERS (Bal)</td><td></td></tr><tr><td></td><td>(exch. for Sovereign Bancorp, Inc. common stock) (1)</td><td>2,350,000</td></tr><tr><td>45,000</td><td>Washington Mutual Capital Trust PIERS units (Baal)</td><td></td></tr><tr><td></td><td>(exch. for Washington Mutual, Inc. common stock)</td><td>2,486,250</td></tr><tr><td></td><td></td><td>9,497,650</td></tr><tr><td></td><td>Energy 2.9%</td><td></td></tr><tr><td>12,500</td><td>Chesapeake Energy Corp. 6% cum. cv. pfd. (B3)</td><td>942,972</td></tr><tr><td>1,000</td><td>Chesapeake Energy Corp. 4.125% cum. cv. pfd. (B3)</td><td></td></tr><tr><td></td><td>(Acquired 03/24/04; Cost $1,000,000) (2)</td><td>1,048,750</td></tr><tr><td>20,000</td><td>The Williams Companies, Inc. 5.50% 2033 jr. sub. cv. deb. (B-)</td><td>1,347,500</td></tr><tr><td></td><td></td><td>3,339,222</td></tr><tr><td></td><td>Entertainment -2.3%</td><td></td></tr><tr><td>22,500</td><td>Emmis Communications Corp. 6.25% series A cum. cv. pfd. (Caal)</td><td>1,065,938</td></tr><tr><td>1,500</td><td>Radio One, Inc. 6.50% HIGH TIDES (B3)</td><td>1,615,500</td></tr><tr><td></td><td></td><td>2,681,438</td></tr><tr><td></td><td>Financial and Insurance - 3.1%</td><td></td></tr><tr><td>20,000</td><td>Reinsurance Group of America, Inc. 5.75% PIERS (Baa2)</td><td>1,148,500</td></tr><tr><td>100,000</td><td>The St. Paul Travelers Companies, Inc. 4.50% 2032 cv. jr. sub. notes (Baal)</td><td>2,457,000</td></tr><tr><td></td><td></td><td>3,605,500</td></tr><tr><td></td><td>Health Care -- 1.68</td><td></td></tr><tr><td>29,000</td><td>Omnicare Capital Trust I 4% PIERS (Ba3)\n(exch. for Omnicare, Inc. common stock) (1)</td><td>1,798,000</td></tr><tr><td></td><td>Mining 0.8%</td><td></td></tr><tr><td>1,000</td><td>Freeport-McMoRan Copper and Gold, Inc. 5.50% cv. perpetual pfd. (CCC)</td><td>882,750</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.5921769312312526
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "TOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "CONVERTIBLE PREFERRED STOCKS",
            "citations": []
          }
        ],
        "label": {
          "value": "TOTAL CONVERTIBLE PREFERRED STOCKS",
          "citations": []
        },
        "fair_value_raw": {
          "value": "23,320,185",
          "citations": []
        },
        "row_text": {
          "value": "TOTAL CONVERTIBLE PREFERRED STOCKS ......................... 23,320,185",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.12990196078431374,
                "top": 0.02904040404040404,
                "width": 0.6919934640522876,
                "height": 0.019570707070707072,
                "page": 4,
                "original_page": 4
              },
              "content": "TOTAL CONVERTIBLE PREFERRED STOCKS ......................... 23,320,185",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.47747147083282465
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          }
        ],
        "label": {
          "value": "MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "21.6%",
          "citations": []
        },
        "row_text": {
          "value": "MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.14052288234233856,
                "top": 0.21906565129756927,
                "width": 0.3651960641145706,
                "height": 0.006313130259513855,
                "page": 4,
                "original_page": null
              },
              "content": "MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Aerospace and Defense",
            "citations": []
          }
        ],
        "label": {
          "value": "Aerospace and Defense -- 1.3%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "1.3%",
          "citations": []
        },
        "row_text": {
          "value": "Aerospace and Defense -- 1.3%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13970588147640228,
                "top": 0.2417929321527481,
                "width": 0.2124183028936386,
                "height": 0.01010100543498993,
                "page": 4,
                "original_page": null
              },
              "content": "1.3% Defense -- and Aerospace",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Aerospace and Defense",
            "citations": []
          }
        ],
        "investment": {
          "value": "Northrop Grumman Corp. 7.25% equity units (NR)",
          "citations": []
        },
        "quantity_raw": {
          "value": "15,000 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "$ 1,569,450",
          "citations": []
        },
        "footnote_markers": [
          {
            "value": "(1)",
            "citations": []
          }
        ],
        "row_text": {
          "value": "15,000 shs Northrop Grumman Corp. 7.25% equity units (NR) (1) $ 1,569,450",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.05964052304625511,
                "top": 0.25505051016807556,
                "width": 0.7647059001028538,
                "height": 0.008207052946090698,
                "page": 4,
                "original_page": null
              },
              "content": "15,000 shs Northrop Grumman Corp. 7.25% equity units (NR) (1) $ 1,569,450",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Banking/Savings and Loan",
            "citations": []
          }
        ],
        "label": {
          "value": "Banking/Savings and Loan -- 1.0%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "1.0%",
          "citations": []
        },
        "row_text": {
          "value": "Banking/Savings and Loan -- 1.0%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.14052288234233856,
                "top": 0.27967172861099243,
                "width": 0.23529411852359772,
                "height": 0.0075757503509521484,
                "page": 4,
                "original_page": null
              },
              "content": "Banking/Savings and Loan -- 1.0%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Banking/Savings and Loan",
            "citations": []
          }
        ],
        "investment": {
          "value": "State Street Corp. 6.75% treasury backed ACES (NR)",
          "citations": []
        },
        "quantity_raw": {
          "value": "5,000 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,159,219",
          "citations": []
        },
        "row_text": {
          "value": "5,000 shs State Street Corp. 6.75% treasury backed ACES (NR) 1,159,219",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.06699346750974655,
                "top": 0.29229798913002014,
                "width": 0.7557189539074898,
                "height": 0.008207052946090698,
                "page": 4,
                "original_page": null
              },
              "content": "5,000 shs State Street Corp. 6.75% treasury backed ACES (NR) 1,159,219",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Consumer Goods",
            "citations": []
          }
        ],
        "label": {
          "value": "Consumer Goods 1.3%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "1.3%",
          "citations": []
        },
        "row_text": {
          "value": "Consumer Goods 1.3%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.14052288234233856,
                "top": 0.3162878751754761,
                "width": 0.16013072431087494,
                "height": 0.0075757503509521484,
                "page": 4,
                "original_page": null
              },
              "content": "Consumer Goods 1.3%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Consumer Goods",
            "citations": []
          }
        ],
        "investment": {
          "value": "Constellation Brands, Inc. dep. shs. representing 5.75% series A mand. cv. pfd. (B).",
          "citations": []
        },
        "quantity_raw": {
          "value": "50,000 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,532,000",
          "citations": []
        },
        "row_text": {
          "value": "50,000 shs Constellation Brands, Inc. dep. shs. representing 5.75% series A mand. cv. pfd. (B). 1,532,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.05964052304625511,
                "top": 0.3289141356945038,
                "width": 0.3439542390406132,
                "height": 0.0075757503509521484,
                "page": 4,
                "original_page": null
              },
              "content": "50,000 shs Constellation Brands, Inc. dep. shs.",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.14052288234233856,
                "top": 0.3289141356945038,
                "width": 0.3145424872636795,
                "height": 0.020202040672302246,
                "page": 4,
                "original_page": null
              },
              "content": "Constellation Brands, Inc. dep. shs. representing 5.75% series A mand. cv. pfd.",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Energy",
            "citations": []
          }
        ],
        "label": {
          "value": "Energy 5.3%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "5.3%",
          "citations": []
        },
        "row_text": {
          "value": "Energy 5.3%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13970588147640228,
                "top": 0.3655303120613098,
                "width": 0.10294117033481598,
                "height": 0.009469687938690186,
                "page": 4,
                "original_page": null
              },
              "content": "5.3% Energy",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Energy",
            "citations": []
          }
        ],
        "investment": {
          "value": "Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)",
          "citations": []
        },
        "quantity_raw": {
          "value": "40,000 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "2,691,600",
          "citations": []
        },
        "row_text": {
          "value": "40,000 shs Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3) 2,691,600",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.05964052304625511,
                "top": 0.3781565725803375,
                "width": 0.44607842341065407,
                "height": 0.008207052946090698,
                "page": 4,
                "original_page": null
              },
              "content": "40,000 shs Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.7573529481887817,
                "top": 0.3781565725803375,
                "width": 0.06617647409439087,
                "height": 0.0075757503509521484,
                "page": 4,
                "original_page": null
              },
              "content": "2,691,600",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Energy",
            "citations": []
          }
        ],
        "investment": {
          "value": "Kerr-McGee Corp. 5.50% 2004 DECS (Baa3) (exch. for Devon Energy Corp. common stock)",
          "citations": []
        },
        "quantity_raw": {
          "value": "30,000 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,565,700",
          "citations": []
        },
        "row_text": {
          "value": "30,000 shs Kerr-McGee Corp. 5.50% 2004 DECS (Baa3) (exch. for Devon Energy Corp. common stock) 1,565,700",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.060457516461610794,
                "top": 0.39078283309936523,
                "width": 0.3651960901916027,
                "height": 0.008207052946090698,
                "page": 4,
                "original_page": null
              },
              "content": "30,000 shs Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.142973855137825,
                "top": 0.40340909361839294,
                "width": 0.31209151446819305,
                "height": 0.0075757503509521484,
                "page": 4,
                "original_page": null
              },
              "content": "(exch. for Devon Energy Corp. common stock)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.7589869499206543,
                "top": 0.40340909361839294,
                "width": 0.06535947322845459,
                "height": 0.006944447755813599,
                "page": 4,
                "original_page": null
              },
              "content": "1,565,700",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Energy",
            "citations": []
          }
        ],
        "investment": {
          "value": "Teekay Shipping Corp. 7.25% PEPS units (BB-)",
          "citations": []
        },
        "quantity_raw": {
          "value": "25,000 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "935,250",
          "citations": []
        },
        "row_text": {
          "value": "25,000 shs Teekay Shipping Corp. 7.25% PEPS units (BB-) 935,250",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.05882352963089943,
                "top": 0.4154040515422821,
                "width": 0.403594758361578,
                "height": 0.008207052946090698,
                "page": 4,
                "original_page": null
              },
              "content": "25,000 shs Teekay Shipping Corp. 7.25% PEPS units (BB-)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.7728758454322815,
                "top": 0.4154040515422821,
                "width": 0.049836575984954834,
                "height": 0.0075757503509521484,
                "page": 4,
                "original_page": null
              },
              "content": "935,250",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Energy",
            "citations": []
          }
        ],
        "investment": {
          "value": "Valero Energy Corp. 2% mandatory cv. pfd. (BB+)",
          "citations": []
        },
        "quantity_raw": {
          "value": "30,000 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "971,520",
          "citations": []
        },
        "row_text": {
          "value": "30,000 shs Valero Energy Corp. 2% mandatory cv. pfd. (BB+) 971,520",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.060457516461610794,
                "top": 0.4273989796638489,
                "width": 0.42320261523127556,
                "height": 0.008207082748413086,
                "page": 4,
                "original_page": null
              },
              "content": "30,000 shs Valero Energy Corp. 2% mandatory cv. pfd. (BB+)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.7728758454322815,
                "top": 0.4273989796638489,
                "width": 0.05065357685089111,
                "height": 0.006944447755813599,
                "page": 4,
                "original_page": null
              },
              "content": "971,520",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Energy",
            "citations": []
          }
        ],
        "label": {
          "value": "Energy Total",
          "citations": []
        },
        "fair_value_raw": {
          "value": "6,164,070",
          "citations": []
        },
        "row_text": {
          "value": "6,164,070",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7589869499206543,
                "top": 0.4526515007019043,
                "width": 0.06535947322845459,
                "height": 0.006944447755813599,
                "page": 4,
                "original_page": null
              },
              "content": "6,164,070",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Financial and Insurance",
            "citations": []
          }
        ],
        "label": {
          "value": "Financial and Insurance -- 5.7%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "5.7%",
          "citations": []
        },
        "row_text": {
          "value": "Financial and Insurance -- 5.7%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.14052288234233856,
                "top": 0.4766414165496826,
                "width": 0.22794117033481598,
                "height": 0.006944447755813599,
                "page": 4,
                "original_page": null
              },
              "content": "Financial and Insurance -- 5.7%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Financial and Insurance",
            "citations": []
          }
        ],
        "investment": {
          "value": "Capital One Financial Corp. 6.25% Upper DECS (Baa3)",
          "citations": []
        },
        "quantity_raw": {
          "value": "45,000 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "2,213,100",
          "citations": []
        },
        "footnote_markers": [
          {
            "value": "(1)",
            "citations": []
          }
        ],
        "row_text": {
          "value": "45,000 shs Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1) 2,213,100",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.05964052304625511,
                "top": 0.4892676770687103,
                "width": 0.48284316435456276,
                "height": 0.008207082748413086,
                "page": 4,
                "original_page": null
              },
              "content": "45,000 shs Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Financial and Insurance",
            "citations": []
          }
        ],
        "investment": {
          "value": "The Chubb Corp. 7% equity units (A)",
          "citations": []
        },
        "quantity_raw": {
          "value": "15,000 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "420,000",
          "citations": []
        },
        "footnote_markers": [
          {
            "value": "(1)",
            "citations": []
          }
        ],
        "row_text": {
          "value": "15,000 shs The Chubb Corp. 7% equity units (A) (1) 420,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.060457516461610794,
                "top": 0.5012626051902771,
                "width": 0.3643790893256664,
                "height": 0.008207082748413086,
                "page": 4,
                "original_page": null
              },
              "content": "15,000 shs The Chubb Corp. 7% equity units (A) (1)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Financial and Insurance",
            "citations": []
          }
        ],
        "investment": {
          "value": "The Chubb Corp. 7% equity units (A)",
          "citations": []
        },
        "quantity_raw": {
          "value": "54,000 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,508,625",
          "citations": []
        },
        "footnote_markers": [
          {
            "value": "(1)",
            "citations": []
          }
        ],
        "row_text": {
          "value": "54,000 shs The Chubb Corp. 7% equity units (A) (1) 1,508,625",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.05964052304625511,
                "top": 0.5138888955116272,
                "width": 0.7638888992369175,
                "height": 0.008207082748413086,
                "page": 4,
                "original_page": null
              },
              "content": "54,000 shs The Chubb Corp. 7% equity units (A) (1) 1,508,625",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Financial and Insurance",
            "citations": []
          }
        ],
        "investment": {
          "value": "Platinum Underwriters Holdings, Ltd. 7% equity security units (NR)",
          "citations": []
        },
        "quantity_raw": {
          "value": "40,000 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,298,000",
          "citations": []
        },
        "footnote_markers": [
          {
            "value": "(1)",
            "citations": []
          }
        ],
        "row_text": {
          "value": "40,000 shs Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1) 1,298,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.05964052304625511,
                "top": 0.5258838534355164,
                "width": 0.5637254752218723,
                "height": 0.008838355541229248,
                "page": 4,
                "original_page": null
              },
              "content": "40,000 shs Platinum Underwriters Holdings, Ltd. 7% equity security units (NR)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Financial and Insurance",
            "citations": []
          }
        ],
        "investment": {
          "value": "XL Capital, Ltd. 6.5% equity security units (A2)",
          "citations": []
        },
        "quantity_raw": {
          "value": "45,000 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,141,875",
          "citations": []
        },
        "row_text": {
          "value": "45,000 shs XL Capital, Ltd. 6.5% equity security units (A2) 1,141,875",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.05964052304625511,
                "top": 0.5385100841522217,
                "width": 0.431372556835413,
                "height": 0.008207082748413086,
                "page": 4,
                "original_page": null
              },
              "content": "45,000 shs XL Capital, Ltd. 6.5% equity security units (A2)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.7589869499206543,
                "top": 0.5391414165496826,
                "width": 0.06454247236251831,
                "height": 0.006313145160675049,
                "page": 4,
                "original_page": null
              },
              "content": "1,141,875",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Financial and Insurance",
            "citations": []
          }
        ],
        "label": {
          "value": "Financial and Insurance Total",
          "citations": []
        },
        "fair_value_raw": {
          "value": "6,581,600",
          "citations": []
        },
        "row_text": {
          "value": "6,581,600",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.758169949054718,
                "top": 0.5631313323974609,
                "width": 0.06454247236251831,
                "height": 0.0075757503509521484,
                "page": 4,
                "original_page": null
              },
              "content": "6,581,600",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Paper and Paper Products",
            "citations": []
          }
        ],
        "label": {
          "value": "Paper and Paper Products -- 1.0%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "1.0%",
          "citations": []
        },
        "row_text": {
          "value": "Paper and Paper Products -- 1.0%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.14052288234233856,
                "top": 0.5871211886405945,
                "width": 0.23366011679172516,
                "height": 0.008207082748413086,
                "page": 4,
                "original_page": null
              },
              "content": "Products -- 1.0% Paper and Paper",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Paper and Paper Products",
            "citations": []
          }
        ],
        "investment": {
          "value": "Temple-Inland, Inc. 7.50% Upper DECS (Baa3)",
          "citations": []
        },
        "quantity_raw": {
          "value": "20,000 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,122,000",
          "citations": []
        },
        "footnote_markers": [
          {
            "value": "(1)",
            "citations": []
          }
        ],
        "row_text": {
          "value": "20,000 shs Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1) 1,122,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.05964052304625511,
                "top": 0.5997474789619446,
                "width": 0.42401960864663124,
                "height": 0.008207082748413086,
                "page": 4,
                "original_page": null
              },
              "content": "20,000 shs Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Pharmaceuticals",
            "citations": []
          }
        ],
        "label": {
          "value": "Pharmaceuticals -- 1.5%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "1.5%",
          "citations": []
        },
        "row_text": {
          "value": "Pharmaceuticals -- 1.5%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.14133986830711365,
                "top": 0.625,
                "width": 0.16830065846443176,
                "height": 0.006313145160675049,
                "page": 4,
                "original_page": null
              },
              "content": "Pharmaceuticals -- 1.5%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Pharmaceuticals",
            "citations": []
          }
        ],
        "investment": {
          "value": "Baxter International, Inc. 7% equity units (A3)",
          "citations": []
        },
        "quantity_raw": {
          "value": "31,500 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,700,055",
          "citations": []
        },
        "footnote_markers": [
          {
            "value": "(1)",
            "citations": []
          }
        ],
        "row_text": {
          "value": "31,500 shs Baxter International, Inc. 7% equity units (A3) (1) 1,700,055",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.060457516461610794,
                "top": 0.6369949579238892,
                "width": 0.7630719058215618,
                "height": 0.008207082748413086,
                "page": 4,
                "original_page": null
              },
              "content": "31,500 shs Baxter International, Inc. 7% equity units (A3) (1) 1,700,055",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Technology",
            "citations": []
          }
        ],
        "label": {
          "value": "Technology -- 3.4%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "3.4%",
          "citations": []
        },
        "row_text": {
          "value": "Technology -- 3.4%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.14052288234233856,
                "top": 0.6609848737716675,
                "width": 0.13153593242168427,
                "height": 0.008838355541229248,
                "page": 4,
                "original_page": null
              },
              "content": "Technology -- 3.4%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Technology",
            "citations": []
          }
        ],
        "investment": {
          "value": "The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3) (exch. for EMC Corp. common stock)",
          "citations": []
        },
        "quantity_raw": {
          "value": "105,550 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,268,342",
          "citations": []
        },
        "row_text": {
          "value": "105,550 shs The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3) (exch. for EMC Corp. common stock) 1,268,342",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.05310457572340965,
                "top": 0.6736111044883728,
                "width": 0.770424846559763,
                "height": 0.020202040672302246,
                "page": 4,
                "original_page": null
              },
              "content": "105,550 shs The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3) (exch. for EMC Corp. common stock) 1,268,342",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Technology",
            "citations": []
          }
        ],
        "investment": {
          "value": "The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3). (exch. for Intel Corp. common stock)",
          "citations": []
        },
        "quantity_raw": {
          "value": "36,395 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "952,130",
          "citations": []
        },
        "row_text": {
          "value": "36,395 shs The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3). (exch. for Intel Corp. common stock) 952,130",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.060457516461610794,
                "top": 0.6982323527336121,
                "width": 0.7638889066874981,
                "height": 0.02020198106765747,
                "page": 4,
                "original_page": null
              },
              "content": "36,395 shs The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3). (exch. for Intel Corp. common stock) 952,130",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Technology",
            "citations": []
          }
        ],
        "investment": {
          "value": "Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A) (linked to LSI Logic Corp. common stock)",
          "citations": []
        },
        "quantity_raw": {
          "value": "$2,000,000",
          "citations": []
        },
        "quantity_type": {
          "value": "principal",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,672,500",
          "citations": []
        },
        "row_text": {
          "value": "$2,000,000 Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A) (linked to LSI Logic Corp. common stock) 1,672,500",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.030228758230805397,
                "top": 0.7228535413742065,
                "width": 0.7941176649183035,
                "height": 0.020833313465118408,
                "page": 4,
                "original_page": null
              },
              "content": "Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A) $2,000,000 (linked to LSI Logic Corp. common stock) 1,672,500",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Technology",
            "citations": []
          }
        ],
        "label": {
          "value": "Technology Total",
          "citations": []
        },
        "fair_value_raw": {
          "value": "3,892,972",
          "citations": []
        },
        "row_text": {
          "value": "3,892,972",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.7589869499206543,
                "top": 0.7594696879386902,
                "width": 0.06372547149658203,
                "height": 0.008207082748413086,
                "page": 4,
                "original_page": null
              },
              "content": "3,892,972",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Utilities",
            "citations": []
          }
        ],
        "label": {
          "value": "Utilities -- 1.1%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "1.1%",
          "citations": []
        },
        "row_text": {
          "value": "Utilities -- 1.1%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.14052288234233856,
                "top": 0.7853535413742065,
                "width": 0.1249999850988388,
                "height": 0.006313145160675049,
                "page": 4,
                "original_page": null
              },
              "content": "Utilities -- 1.1%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          },
          {
            "value": "Utilities",
            "citations": []
          }
        ],
        "investment": {
          "value": "DTE Energy Co. 8.75% equity security units (BBB)",
          "citations": []
        },
        "quantity_raw": {
          "value": "50,000 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "1,234,500",
          "citations": []
        },
        "footnote_markers": [
          {
            "value": "(1)",
            "citations": []
          }
        ],
        "row_text": {
          "value": "50,000 shs DTE Energy Co. 8.75% equity security units (BBB) (1) 1,234,500",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.05964052304625511,
                "top": 0.7967171669006348,
                "width": 0.45996731892228127,
                "height": 0.008207082748413086,
                "page": 4,
                "original_page": null
              },
              "content": "50,000 shs DTE Energy Co. 8.75% equity security units (BBB) (1)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "TOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "MANDATORY CONVERTIBLE SECURITIES",
            "citations": []
          }
        ],
        "label": {
          "value": "TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).",
          "citations": []
        },
        "fair_value_raw": {
          "value": "24,955,866",
          "citations": []
        },
        "row_text": {
          "value": "TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e). 24,955,866",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.14133986830711365,
                "top": 0.8219696879386902,
                "width": 0.3513071835041046,
                "height": 0.006944477558135986,
                "page": 4,
                "original_page": null
              },
              "content": "TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.7508170008659363,
                "top": 0.8213383555412292,
                "width": 0.07271242141723633,
                "height": 0.007575809955596924,
                "page": 4,
                "original_page": null
              },
              "content": "24,955,866",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "COMMON STOCKS",
            "citations": []
          }
        ],
        "label": {
          "value": "COMMON STOCKS -- 0.0%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "0.0%",
          "citations": []
        },
        "row_text": {
          "value": "COMMON STOCKS -- 0.0%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.14052288234233856,
                "top": 0.8453282713890076,
                "width": 0.15359477698802948,
                "height": 0.0075757503509521484,
                "page": 4,
                "original_page": null
              },
              "content": "COMMON STOCKS -- 0.0%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "COMMON STOCKS",
            "citations": []
          },
          {
            "value": "Telecommunications",
            "citations": []
          }
        ],
        "label": {
          "value": "Telecommunications -- 0.0%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "0.0%",
          "citations": []
        },
        "row_text": {
          "value": "Telecommunications -- 0.0%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.14052288234233856,
                "top": 0.8712121248245239,
                "width": 0.19199346005916595,
                "height": 0.006313145160675049,
                "page": 4,
                "original_page": null
              },
              "content": "Telecommunications -- 0.0%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "COMMON STOCKS",
            "citations": []
          },
          {
            "value": "Telecommunications",
            "citations": []
          }
        ],
        "investment": {
          "value": "Covad Communications Group, Inc.",
          "citations": []
        },
        "quantity_raw": {
          "value": "11,743 shs",
          "citations": []
        },
        "quantity_type": {
          "value": "shares",
          "citations": []
        },
        "fair_value_raw": {
          "value": "23,486",
          "citations": []
        },
        "footnote_markers": [
          {
            "value": "(3)",
            "citations": []
          }
        ],
        "row_text": {
          "value": "11,743 shs Covad Communications Group, Inc. (3) 23,486",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.05964052304625511,
                "top": 0.8832070827484131,
                "width": 0.3431372679769993,
                "height": 0.008207082748413086,
                "page": 4,
                "original_page": null
              },
              "content": "11,743 shs Covad Communications Group, Inc. (3)",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.7802287340164185,
                "top": 0.8838383555412292,
                "width": 0.04411768913269043,
                "height": 0.006313145160675049,
                "page": 4,
                "original_page": null
              },
              "content": "23,486",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "TOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "COMMON STOCKS",
            "citations": []
          }
        ],
        "label": {
          "value": "TOTAL COMMON STOCKS",
          "citations": []
        },
        "fair_value_raw": {
          "value": "23,486",
          "citations": []
        },
        "row_text": {
          "value": "TOTAL COMMON STOCKS 23,486",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.14133986830711365,
                "top": 0.9084596037864685,
                "width": 0.13807189464569092,
                "height": 0.006313145160675049,
                "page": 4,
                "original_page": null
              },
              "content": "TOTAL COMMON STOCKS",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            },
            {
              "type": "Text",
              "bbox": {
                "left": 0.7802287340164185,
                "top": 0.9078282713890076,
                "width": 0.04411768913269043,
                "height": 0.006313145160675049,
                "page": 4,
                "original_page": null
              },
              "content": "23,486",
              "image_url": null,
              "chart_data": null,
              "confidence": "low",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.6588498327790238
              },
              "extra": null,
              "parentBlock": {
                "type": "Table",
                "bbox": {
                  "left": 0.02369281045751634,
                  "top": 0.15656565656565657,
                  "width": 0.8112745098039216,
                  "height": 0.7689393939393939,
                  "page": 4,
                  "original_page": null
                },
                "content": "<table><tr><th>Principal\nAmount\nor Shares</th><th></th><th>Value\n(Note 1)</th></tr><tr><td></td><td>MANDATORY CONVERTIBLE SECURITIES-- 21.6% Note 1(e)</td><td></td></tr><tr><td></td><td>Aerospace and Defense -- 1.3%</td><td></td></tr><tr><td>15,000 shs</td><td>Northrop Grumman Corp. 7.25% equity units (NR) (1)</td><td>$ 1,569,450</td></tr><tr><td></td><td>Banking/Savings and Loan -- 1.0%</td><td></td></tr><tr><td>5,000 shs</td><td>State Street Corp. 6.75% treasury backed ACES (NR)</td><td>1,159,219</td></tr><tr><td></td><td>Consumer Goods 1.3%</td><td></td></tr><tr><td>50,000 shs</td><td>Constellation Brands, Inc. dep. shs.</td><td></td></tr><tr><td></td><td>representing 5.75% series A mand. cv. pfd. (B).</td><td>1,532,000</td></tr><tr><td></td><td>Energy 5.3%</td><td></td></tr><tr><td>40,000 shs</td><td>Amerada Hess Corp.7% mandatory cv. pfd. ACES (Ba3)</td><td>2,691,600</td></tr><tr><td>30,000 shs</td><td>Kerr-McGee Corp. 5.50% 2004 DECS (Baa3)</td><td></td></tr><tr><td></td><td>(exch. for Devon Energy Corp. common stock)</td><td>1,565,700</td></tr><tr><td>25,000 shs</td><td>Teekay Shipping Corp. 7.25% PEPS units (BB-)</td><td>935,250</td></tr><tr><td>30,000 shs</td><td>Valero Energy Corp. 2% mandatory cv. pfd. (BB+)</td><td>971,520</td></tr><tr><td></td><td></td><td>6,164,070</td></tr><tr><td></td><td>Financial and Insurance -- 5.7%</td><td></td></tr><tr><td>45,000 shs</td><td>Capital One Financial Corp. 6.25% Upper DECS (Baa3) (1)</td><td>2,213,100</td></tr><tr><td>15,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>420,000</td></tr><tr><td>54,000 shs</td><td>The Chubb Corp. 7% equity units (A) (1)</td><td>1,508,625</td></tr><tr><td>40,000 shs</td><td>Platinum Underwriters Holdings, Ltd. 7% equity security units (NR) (1)</td><td>1,298,000</td></tr><tr><td>45,000 shs</td><td>XL Capital, Ltd. 6.5% equity security units (A2)</td><td>1,141,875</td></tr><tr><td></td><td></td><td>6,581,600</td></tr><tr><td></td><td>Paper and Paper Products -- 1.0%</td><td></td></tr><tr><td>20,000 shs</td><td>Temple-Inland, Inc. 7.50% Upper DECS (Baa3) (1)</td><td>1,122,000</td></tr><tr><td></td><td>Pharmaceuticals -- 1.5%</td><td></td></tr><tr><td>31,500 shs</td><td>Baxter International, Inc. 7% equity units (A3) (1)</td><td>1,700,055</td></tr><tr><td></td><td>Technology -- 3.4%</td><td></td></tr><tr><td>105,550 shs</td><td>The Goldman Sachs Group, Inc. 7.50% mandatory exch. notes (Aa3)\n(exch. for EMC Corp. common stock)</td><td>1,268,342</td></tr><tr><td>36,395 shs</td><td>The Goldman Sachs Group, Inc. 5.625% mandatory exch. notes (Aa3).</td><td></td></tr><tr><td></td><td>(exch. for Intel Corp. common stock)</td><td>952,130</td></tr><tr><td>$2,000,000</td><td>Lehman Brothers Holdings, Inc. 6% 2005 YEELDS (A)</td><td></td></tr><tr><td></td><td>(linked to LSI Logic Corp. common stock)</td><td>1,672,500</td></tr><tr><td></td><td></td><td>3,892,972</td></tr><tr><td></td><td>Utilities -- 1.1%</td><td></td></tr><tr><td>50,000 shs</td><td>DTE Energy Co. 8.75% equity security units (BBB) (1)</td><td>1,234,500</td></tr><tr><td></td><td>TOTAL MANDATORY CONVERTIBLE SECURITIES Note 1(e).</td><td>24,955,866</td></tr><tr><td></td><td>COMMON STOCKS -- 0.0%</td><td></td></tr><tr><td></td><td>Telecommunications -- 0.0%</td><td></td></tr><tr><td>11,743 shs</td><td>Covad Communications Group, Inc. (3)</td><td>23,486</td></tr><tr><td></td><td>TOTAL COMMON STOCKS</td><td>23,486</td></tr></table>",
                "image_url": null,
                "chart_data": null,
                "confidence": "low",
                "granular_confidence": {
                  "extract_confidence": null,
                  "parse_confidence": 0.6588498327790238
                },
                "extra": null
              }
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "SHORT-TERM SECURITIES",
            "citations": []
          }
        ],
        "label": {
          "value": "SHORT-TERM SECURITIES -- 4.6%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "4.6%",
          "citations": []
        },
        "row_text": {
          "value": "SHORT-TERM SECURITIES -- 4.6%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13398692810457516,
                "top": 0.16540404040404041,
                "width": 0.21241830065359477,
                "height": 0.0069444444444444475,
                "page": 5,
                "original_page": 5
              },
              "content": "SHORT-TERM SECURITIES -- 4.6%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.652794361114502
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "SHORT-TERM SECURITIES",
            "citations": []
          },
          {
            "value": "Commercial Paper",
            "citations": []
          }
        ],
        "label": {
          "value": "Commercial Paper -- 4.6%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "4.6%",
          "citations": []
        },
        "row_text": {
          "value": "Commercial Paper -- 4.6%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.1323529411764706,
                "top": 0.1893939393939394,
                "width": 0.1772875816993464,
                "height": 0.006944444444444444,
                "page": 5,
                "original_page": 5
              },
              "content": "Commercial Paper -- 4.6%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.652794361114502
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "SHORT-TERM SECURITIES",
            "citations": []
          },
          {
            "value": "Commercial Paper",
            "citations": []
          }
        ],
        "investment": {
          "value": "American Express Credit Corp. (P1) (0.99% maturing 05/03/04)",
          "citations": []
        },
        "quantity_raw": {
          "value": "$2,900,000",
          "citations": []
        },
        "quantity_type": {
          "value": "principal",
          "citations": []
        },
        "fair_value_raw": {
          "value": "$ 2,899,601",
          "citations": []
        },
        "maturity_date": {
          "value": "05/03/04",
          "citations": []
        },
        "interest_rate_raw": {
          "value": "0.99%",
          "citations": []
        },
        "row_text": {
          "value": "$2,900,000 American Express Credit Corp. (P1) (0.99% maturing 05/03/04)........................................................ $ 2,899,601",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.03022875816993464,
                "top": 0.1994949494949495,
                "width": 0.7867647058823529,
                "height": 0.02335858585858586,
                "page": 5,
                "original_page": 5
              },
              "content": "$2,900,000 American Express Credit Corp. (P1) (0.99% maturing 05/03/04)........................................................ $ 2,899,601",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.652794361114502
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "SHORT-TERM SECURITIES",
            "citations": []
          },
          {
            "value": "Commercial Paper",
            "citations": []
          }
        ],
        "investment": {
          "value": "American Express Credit Corp. (P1) (1.02% maturing 05/06/04)",
          "citations": []
        },
        "quantity_raw": {
          "value": "2,400,000",
          "citations": []
        },
        "quantity_type": {
          "value": "principal",
          "citations": []
        },
        "fair_value_raw": {
          "value": "2,399,592",
          "citations": []
        },
        "maturity_date": {
          "value": "05/06/04",
          "citations": []
        },
        "interest_rate_raw": {
          "value": "1.02%",
          "citations": []
        },
        "row_text": {
          "value": "2,400,000 American Express Credit Corp. (P1) (1.02% maturing 05/06/04)........................................................ 2,399,592",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.03758169934640523,
                "top": 0.22601010101010102,
                "width": 0.7785947712418301,
                "height": 0.020202020202020204,
                "page": 5,
                "original_page": 5
              },
              "content": "2,400,000 American Express Credit Corp. (P1) (1.02% maturing 05/06/04)........................................................ 2,399,592",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.652794361114502
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "SHORT-TERM SECURITIES",
            "citations": []
          },
          {
            "value": "Commercial Paper",
            "citations": []
          }
        ],
        "label": {
          "value": "Commercial Paper Total",
          "citations": []
        },
        "fair_value_raw": {
          "value": "5,299,193",
          "citations": []
        },
        "row_text": {
          "value": "5,299,193",
          "citations": [
            {
              "type": "Key Value",
              "bbox": {
                "left": 0.75,
                "top": 0.26262626262626265,
                "width": 0.06617647058823528,
                "height": 0.008838383838383812,
                "page": 5,
                "original_page": 5
              },
              "content": "5,299,193",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.652794361114502
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "SUBTOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "SHORT-TERM SECURITIES",
            "citations": []
          },
          {
            "value": "U.S. Government Obligations",
            "citations": []
          }
        ],
        "label": {
          "value": "U.S. Government Obligations -- 0.0%",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "0.0%",
          "citations": []
        },
        "row_text": {
          "value": "U.S. Government Obligations -- 0.0%",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993464052287,
                "top": 0.288510101010101,
                "width": 0.25735294117647056,
                "height": 0.007575757575757569,
                "page": 5,
                "original_page": 5
              },
              "content": "U.S. Government Obligations -- 0.0%",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.652794361114502
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "HOLDING",
          "citations": []
        },
        "section_path": [
          {
            "value": "SHORT-TERM SECURITIES",
            "citations": []
          },
          {
            "value": "U.S. Government Obligations",
            "citations": []
          }
        ],
        "investment": {
          "value": "U.S. Treasury notes 1.625% 4/30/05 (Aaa)",
          "citations": []
        },
        "quantity_raw": {
          "value": "11,000",
          "citations": []
        },
        "quantity_type": {
          "value": "principal",
          "citations": []
        },
        "fair_value_raw": {
          "value": "11,000",
          "citations": []
        },
        "maturity_date": {
          "value": "4/30/05",
          "citations": []
        },
        "interest_rate_raw": {
          "value": "1.625%",
          "citations": []
        },
        "footnote_markers": [
          {
            "value": "(4)",
            "citations": []
          }
        ],
        "row_text": {
          "value": "11,000 U.S. Treasury notes 1.625% 4/30/05 (Aaa) (4)..................................... 11,000",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.059640522875817,
                "top": 0.2986111111111111,
                "width": 0.7573529411764706,
                "height": 0.008838383838383838,
                "page": 5,
                "original_page": 5
              },
              "content": "11,000 U.S. Treasury notes 1.625% 4/30/05 (Aaa) (4)..................................... 11,000",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.652794361114502
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "TOTAL",
          "citations": []
        },
        "section_path": [
          {
            "value": "SHORT-TERM SECURITIES",
            "citations": []
          }
        ],
        "label": {
          "value": "TOTAL SHORT-TERM SECURITIES",
          "citations": []
        },
        "fair_value_raw": {
          "value": "5,310,193",
          "citations": []
        },
        "row_text": {
          "value": "TOTAL SHORT-TERM SECURITIES...................................................... 5,310,193",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.1315359477124183,
                "top": 0.32386363636363635,
                "width": 0.684640522875817,
                "height": 0.008207070707070708,
                "page": 5,
                "original_page": 5
              },
              "content": "TOTAL SHORT-TERM SECURITIES...................................................... 5,310,193",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.652794361114502
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "TOTAL",
          "citations": []
        },
        "label": {
          "value": "Total Investments",
          "citations": []
        },
        "fair_value_raw": {
          "value": "115,597,141",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "100.0%",
          "citations": []
        },
        "row_text": {
          "value": "Total Investments -- 100.0%...................................................... 115,597,141",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.1315359477124183,
                "top": 0.34785353535353536,
                "width": 0.20098039215686275,
                "height": 0.008838383838383838,
                "page": 5,
                "original_page": 5
              },
              "content": "Total Investments -- 100.0%...................................................... 115,597,141",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.652794361114502
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "TOTAL",
          "citations": []
        },
        "label": {
          "value": "Other assets and liabilities, net",
          "citations": []
        },
        "fair_value_raw": {
          "value": "(44,631)",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "(0.0)%",
          "citations": []
        },
        "row_text": {
          "value": "Other assets and liabilities, net -- (0.0)%...................................... (44,631)",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.13316993464052287,
                "top": 0.36047979797979796,
                "width": 0.315359477124183,
                "height": 0.008838383838383838,
                "page": 5,
                "original_page": 5
              },
              "content": "Other assets and liabilities, net -- (0.0)%...................................... (44,631)",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.652794361114502
              },
              "extra": null
            }
          ]
        }
      },
      {
        "row_type": {
          "value": "TOTAL",
          "citations": []
        },
        "label": {
          "value": "Total Net Assets",
          "citations": []
        },
        "fair_value_raw": {
          "value": "$115,552,510",
          "citations": []
        },
        "percent_net_assets_raw": {
          "value": "100.0%",
          "citations": []
        },
        "row_text": {
          "value": "Total Net Assets -- 100.0%....................................................... $115,552,510",
          "citations": [
            {
              "type": "Text",
              "bbox": {
                "left": 0.1315359477124183,
                "top": 0.38636363636363635,
                "width": 0.5816993464052288,
                "height": 0.008207070707070708,
                "page": 5,
                "original_page": 5
              },
              "content": "Total Net Assets -- 100.0%....................................................... $115,552,510",
              "image_url": null,
              "chart_data": null,
              "confidence": "high",
              "granular_confidence": {
                "extract_confidence": null,
                "parse_confidence": 0.652794361114502
              },
              "extra": null
            }
          ]
        }
      }
    ]
  },
  "usage": {
    "num_fields": 1032,
    "num_pages": 5,
    "credits": 24.0
  },
  "job_id": "cbfa12fe-a81a-48f8-aab3-4dfd847dbcac",
  "studio_link": "https://studio.reducto.ai/job/cbfa12fe-a81a-48f8-aab3-4dfd847dbcac"
}